Dietary interventions for adults with chronic kidney disease by Palmer, Suetonia C et al.
Bond University
Research Repository
Dietary interventions for adults with chronic kidney disease
Palmer, Suetonia C; Maggo, Jasjot K; Campbell, Katrina L.; Craig, Jonathan C.; Johnson,
David W.; Sutanto, Bernadet; Ruospo, Marinella; Tong, Allison; Strippoli, Giovanni F M
Published in:
Cochrane Database of Systematic Reviews
DOI:
10.1002/14651858.CD011998.pub2
Published: 23/04/2017
Document Version:
Publisher's PDF, also known as Version of record
Link to publication in Bond University research repository.
Recommended citation(APA):
Palmer, S. C., Maggo, J. K., Campbell, K. L., Craig, J. C., Johnson, D. W., Sutanto, B., ... Strippoli, G. F. M.
(2017). Dietary interventions for adults with chronic kidney disease. Cochrane Database of Systematic Reviews,
2017(4), [CD011998]. https://doi.org/10.1002/14651858.CD011998.pub2
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
For more information, or if you believe that this document breaches copyright, please contact the Bond University research repository
coordinator.
Download date: 06 Nov 2019
Cochrane Database of Systematic Reviews
Dietary interventions for adults with chronic kidney disease
(Review)
Palmer SC, Maggo JK, Campbell KL, Craig JC, Johnson DW, Sutanto B, Ruospo M, Tong A,
Strippoli GFM
Palmer SC, Maggo JK, Campbell KL, Craig JC, Johnson DW, Sutanto B, Ruospo M, Tong A, Strippoli GFM.
Dietary interventions for adults with chronic kidney disease.
Cochrane Database of Systematic Reviews 2017, Issue 4. Art. No.: CD011998.
DOI: 10.1002/14651858.CD011998.pub2.
www.cochranelibrary.com
Dietary interventions for adults with chronic kidney disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . . . . . . . . . . . . . . . . . . .
6BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Figure 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Figure 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
17DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
19AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
20ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
20REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
24CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
60DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Analysis 1.1. Comparison 1 Dietary intervention versus control, Outcome 1 All-cause mortality. . . . . . . . 62
Analysis 1.2. Comparison 1 Dietary intervention versus control, Outcome 2 Cardiovascular mortality. . . . . . 63
Analysis 1.3. Comparison 1 Dietary intervention versus control, Outcome 3 Health-related quality of life (SF-36) score. 63
Analysis 1.4. Comparison 1 Dietary intervention versus control, Outcome 4 End-stage kidney disease. . . . . . 64
Analysis 1.5. Comparison 1 Dietary intervention versus control, Outcome 5 Doubling of serum creatinine. . . . . 65
Analysis 1.6. Comparison 1 Dietary intervention versus control, Outcome 6 Employment. . . . . . . . . . 65
Analysis 1.7. Comparison 1 Dietary intervention versus control, Outcome 7 Dietary adherence. . . . . . . . 66
Analysis 1.8. Comparison 1 Dietary intervention versus control, Outcome 8 Worsening nutrition. . . . . . . . 66
Analysis 1.9. Comparison 1 Dietary intervention versus control, Outcome 9 eGFR [mL/min/1.73 m2]. . . . . . 67
Analysis 1.10. Comparison 1 Dietary intervention versus control, Outcome 10 Serum creatinine. . . . . . . . 68
Analysis 1.11. Comparison 1 Dietary intervention versus control, Outcome 11 Systolic blood pressure. . . . . . 69
Analysis 1.12. Comparison 1 Dietary intervention versus control, Outcome 12 Diastolic blood pressure. . . . . . 70
Analysis 1.13. Comparison 1 Dietary intervention versus control, Outcome 13 Energy intake. . . . . . . . . 71
Analysis 1.14. Comparison 1 Dietary intervention versus control, Outcome 14 Body weight. . . . . . . . . . 72
Analysis 1.15. Comparison 1 Dietary intervention versus control, Outcome 15 BMI. . . . . . . . . . . . 73
Analysis 1.16. Comparison 1 Dietary intervention versus control, Outcome 16 Waist-hip ratio. . . . . . . . . 73
Analysis 1.17. Comparison 1 Dietary intervention versus control, Outcome 17 Waist circumference, cm. . . . . 74
Analysis 1.18. Comparison 1 Dietary intervention versus control, Outcome 18 Arm circumference. . . . . . . 74
Analysis 1.19. Comparison 1 Dietary intervention versus control, Outcome 19 Serum albumin. . . . . . . . . 75
Analysis 1.20. Comparison 1 Dietary intervention versus control, Outcome 20 Serum LDL cholesterol. . . . . . 76
Analysis 2.1. Comparison 2 Mediterranean diet versus low fat, Outcome 1 Serum LDL cholesterol. . . . . . . 76
Analysis 3.1. Comparison 3 Fruits and vegetables versus bicarbonate, Outcome 1 eGFR [mL/min/1.73 m2]. . . . 77
Analysis 3.2. Comparison 3 Fruits and vegetables versus bicarbonate, Outcome 2 Serum creatinine. . . . . . . 77
Analysis 3.3. Comparison 3 Fruits and vegetables versus bicarbonate, Outcome 3 Systolic blood pressure. . . . . 78
Analysis 3.4. Comparison 3 Fruits and vegetables versus bicarbonate, Outcome 4 Body weight. . . . . . . . . 78
79ADDITIONAL TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
114APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
121CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
121DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
121DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . .
122INDEX TERMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iDietary interventions for adults with chronic kidney disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Review]
Dietary interventions for adults with chronic kidney disease
Suetonia C Palmer1, Jasjot K Maggo1 , Katrina L Campbell2, Jonathan C Craig3,4, David W Johnson5 , Bernadet Sutanto6, Marinella
Ruospo7 ,8, Allison Tong3 ,6, Giovanni FM Strippoli3,4,7,9,10
1Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand. 2Faculty of Health Science and Medicine,
Bond University, Robina, Australia. 3Sydney School of Public Health, The University of Sydney, Sydney, Australia. 4Cochrane Kidney
and Transplant, Centre for Kidney Research, The Children’s Hospital at Westmead, Westmead, Australia. 5Department of Nephrology,
Princess Alexandra Hospital, Woolloongabba, Australia. 6Centre for Kidney Research, The Children’s Hospital at Westmead, West-
mead, Australia. 7Medical Scientific Office, Diaverum, Lund, Sweden. 8Division of Nephrology and Transplantation, Department
of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy. 9Department of Emergency and Organ
Transplantation, University of Bari, Bari, Italy. 10Diaverum Academy, Bari, Italy
Contact address: Giovanni FM Strippoli, Cochrane Kidney and Transplant, Centre for Kidney Research, The Children’s Hospital at
Westmead, Westmead, NSW, 2145, Australia. giovanni.strippoli@uniba.it, gfmstrippoli@gmail.com.
Editorial group: Cochrane Kidney and Transplant Group.
Publication status and date: New, published in Issue 4, 2017.
Citation: Palmer SC, Maggo JK, Campbell KL, Craig JC, Johnson DW, Sutanto B, Ruospo M, Tong A, Strippoli GFM. Dietary
interventions for adults with chronic kidney disease. Cochrane Database of Systematic Reviews 2017, Issue 4. Art. No.: CD011998. DOI:
10.1002/14651858.CD011998.pub2.
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
Dietary changes are routinely recommended in people with chronic kidney disease (CKD) on the basis of randomised evidence in the
general population and non-randomised studies in CKD that suggest certain healthy eating patterns may prevent cardiovascular events
and lower mortality. People who have kidney disease have prioritised dietary modifications as an important treatment uncertainty.
Objectives
This review evaluated the benefits and harms of dietary interventions among adults with CKD including people with end-stage kidney
disease (ESKD) treated with dialysis or kidney transplantation.
Search methods
We searched the Cochrane Kidney and Transplant Specialised Register (up to 31 January 2017) through contact with the Information
Specialist using search terms relevant to this review. Studies contained in the Specialised Register are identified through search strategies
specifically designed forCENTRAL,MEDLINE, andEMBASE; handsearching conference proceedings; and searching the International
Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov.
Selection criteria
Randomised controlled trials (RCTs) or quasi-randomised RCTs of dietary interventions versus other dietary interventions, lifestyle
advice, or standard care assessing mortality, cardiovascular events, health-related quality of life, and biochemical, anthropomorphic,
and nutritional outcomes among people with CKD.
Data collection and analysis
Two authors independently screened studies for inclusion and extracted data. Results were summarised as risk ratios (RR) for dichoto-
mous outcomes or mean differences (MD) or standardised MD (SMD) for continuous outcomes, with 95% confidence intervals (CI)
or in descriptive format when meta-analysis was not possible. Confidence in the evidence was assessed using GRADE.
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Main results
We included 17 studies involving 1639 people with CKD. Three studies enrolled 341 people treated with dialysis, four studies enrolled
168 kidney transplant recipients, and 10 studies enrolled 1130 people with CKD stages 1 to 5. Eleven studies (900 people) evaluated
dietary counselling with or without lifestyle advice and six evaluated dietary patterns (739 people), including one study (191 people)
of a carbohydrate-restricted low-iron, polyphenol enriched diet, two studies (181 people) of increased fruit and vegetable intake, two
studies (355 people) of a Mediterranean diet and one study (12 people) of a high protein/low carbohydrate diet. Risks of bias in the
included studies were generally high or unclear, lowering confidence in the results. Participants were followed up for a median of 12
months (range 1 to 46.8 months).
Studies were not designed to examine all-cause mortality or cardiovascular events. In very-low quality evidence, dietary interventions had
uncertain effects on all-cause mortality or ESKD. In absolute terms, dietary interventions may prevent one person in every 3000 treated
for one year avoiding ESKD, although the certainty in this effect was very low. Across all 17 studies, outcome data for cardiovascular
events were sparse. Dietary interventions in low quality evidence were associated with a higher health-related quality of life (2 studies,
119 people: MD in SF-36 score 11.46, 95% CI 7.73 to 15.18; I2 = 0%). Adverse events were generally not reported.
Dietary interventions lowered systolic blood pressure (3 studies, 167 people: MD -9.26 mm Hg, 95% CI -13.48 to -5.04; I2 = 80%)
and diastolic blood pressure (2 studies, 95 people: MD -8.95, 95% CI -10.69 to -7.21; I2 = 0%) compared to a control diet. Dietary
interventions were associated with a higher estimated glomerular filtration rate (eGFR) (5 studies, 219 people: SMD 1.08; 95% CI 0.26
to 1.97; I2 = 88%) and serum albumin levels (6 studies, 541 people: MD 0.16 g/dL, 95% CI 0.07 to 0.24; I2 = 26%). A Mediterranean
diet lowered serum LDL cholesterol levels (1 study, 40 people: MD -1.00 mmol/L, 95% CI -1.56 to -0.44).
Authors’ conclusions
Dietary interventions have uncertain effects on mortality, cardiovascular events and ESKD among people with CKD as these outcomes
were rarely measured or reported. Dietary interventions may increase health-related quality of life, eGFR, and serum albumin, and
lower blood pressure and serum cholesterol levels.
Based on stakeholder prioritisation of dietary research in the setting of CKD and preliminary evidence of beneficial effects on risks
factors for clinical outcomes, large-scale pragmatic RCTs to test the effects of dietary interventions on patient outcomes are required.
P L A I N L A N G U A G E S U M M A R Y
Dietary patterns for adults with chronic kidney disease
What is the issue?
People who have kidney disease can experience a lower life expectancy, complications including heart disease, and may need treatment
for severe kidney failure, such as dialysis. Patients and doctors wish to identify treatments that protect people against kidney failure or
heart disease. For both doctors and people who have kidney disease, lifestyle changes such as diet are very important as possible ways
to improve health and well-being, and provide people with a chance to ’self-manage’ their care for kidney disease.
What did we do?
We combined all studies looking at dietary changes for people who kidney disease including people treated with dialysis or who have a
kidney transplant.
What did we find?
We found 17 studies involving 1639 people who had chronic kidney disease that looked into whether diet changes or advice improved
their health. Studies included men and women with mainly moderate or severe kidney disease. Diets involved increasing fruit and
vegetable intake, increasing poultry and fish, higher nut and olive oil use, and some increases in cereals and legumes (e.g. beans), and less
red meat, sugar, and salt. We looked particularly at three key outcomes: the risk of death, the risk of advanced kidney disease requiring
dialysis, and quality of life. There were four studies involving people who have had a kidney transplant and three studies involving
people treated with dialysis.
After combining the available studies, it was uncertain whether making healthy diet changes prevented heart complications as most
studies did not measure these. Diet changes may improve life quality. We did see that some risk factors for future disease, such as blood
pressure and cholesterol, were lower following diet counselling or healthier eating.
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The quality of the included studies was often very low meaning we could not be sure that future studies would find similar results.
Conclusions
We are very uncertain whether dietary changes improve well-being for people with kidney disease because the available research studies
were not designed to learn about these. Diet changes may lower blood pressure and cholesterol, but the longer term impact of these
effects on well-being is not proven. This means we still need large and good-quality research studies to help understand the impact of
diet on the health of people with kidney disease.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Dietary modifications (counselling or dietary change) versus control for CKD
Patient or population: people with CKD
Intervention: dietary modif icat ions
Comparison: control
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Standard care Dietary intervention
Death High risk population Not est imable 539 (5) ⊕
very low1,2,3
Studies were not de-
signed to measure ef -
fects of dietary inter-
vent ions on mortality
150 per 1000 Not est imable
Medium risk population
25 per 1000 Not est imable
Major cardiovascular
event
High risk population Not est imable Insuf f icient data obser-
vat ions
No studies were avail-
able for this outcome
Studies were not de-
signed to measure ef -
fects of dietary inter-
vent ions on cardiovas-
cular events. 0 studies
reported major cardio-
vascular events
150 per 1000 Not est imable
Medium risk population
45 per 1000 Not est imable
Progression to ESKD
Measured as requiring
dialysis treatment in
people with CKD
0.6 per 1000 0.3 per 1000 RR 0.53
(0.26 to 1.07)
242 (2) ⊕
very low1,2,3,4
29 part icipants devel-
oped ESKD in these
studies. No studies in-
cluded recipients of a
kidney transplant
4
D
ie
ta
r
y
in
te
r
v
e
n
tio
n
s
fo
r
a
d
u
lts
w
ith
c
h
ro
n
ic
k
id
n
e
y
d
ise
a
se
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
7
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
Health- related quality
of life
Measured using the
Short Form-36 scale
f rom 0 to 100
The mean SF-36 score
ranged across control
groups f rom 43.6 to 48.
8
The mean SF-36 score
in the intervent ion
groups was 11.46
higher (95% CI 7.73 to
15.18)
119 (2) ⊕⊕
low1,3
0 studies included re-
cipients of a kidney
transplant. None of the
studies were blinded
* The basis for the assumed risk of mortality (e.g. the median control group risk across studies) was obtained f rom the absolute populat ion risk est imated f rom previously
published cohort studies or data registries (Johnson 2011; Weiner 2006). The corresponding risk (and its 95% conf idence interval) is based on the assumed risk in the
comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RR: Risk Ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Study lim itat ions were due to high or unclear risks of bias
2 Conf idence interval includes range of plausible values that include substant ial benef it or harm
3 Based on few events and/ or part icipants across all studies
4 Data not available for recipients of a kidney transplant
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B A C K G R O U N D
Description of the condition
Chronic kidney disease (CKD) is a disorder resulting from struc-
tural changes to the kidney (cysts, loss of tissue, or masses) and/or
urinary tract leading to changes in the composition of the urine,
reduced kidney function or both. The kidney is a target organ in-
jured in diseases primary to the kidney (such as glomerulonephritis
or polycystic kidney disease) and secondary diseases (including car-
diovascular disease, metabolic syndrome, diabetes (predominantly
type 2), obesity, and arterial hypertension). Secondary causes of
kidney failure now dominate the global epidemiology of kidney
disease - diabetes and hypertension are the leading causes of CKD
in middle and higher income countries worldwide, accounting for
approximately 35% and 25% of kidney disease (Jha 2013). Kid-
ney tissue in systemic diseases is injured by accelerated vascular
damage, glomerular hypertension, and increased cellular glycosy-
lation and oxidation.
Overall, CKD affects an estimated 10% to 15% of people around
the world (Chadban 2003; Singh 2009; Zhang 2012) and leads to
poorer health outcomes for affected individuals and communities.
Among people who havemoderate to severe CKD, early death and
cardiovascular complications are two to three times more likely
than for peoplewithout kidney disease andquality of life is reduced
(Go 2004; Hemmelgarn 2010; Wyld 2012).
Description of the intervention
Dietary modifications (dietary intake of whole foods rather than
single dietary nutrients, such as sodium or protein) may play an
important and complex role in the aetiology and progression of
CKD, in part through modification of systemic disease processes
affecting kidney function (arterial hypertension, tissue glycosyla-
tion, glomerular injury, and macrovascular and microvascular dis-
eases) and in part through altering the risks of non-communicable
diseases such as diabetes that play such an important role in the
prevalence of kidney disease in developed and developing nations.
Individual dietary components may influence blood lipid levels,
oxidative stress, insulin sensitivity, blood pressure, systemic in-
flammatory responses, pro fibrotic processes, thrombosis risk, and
endothelial function to modify clinical outcomes (Abiemo 2012;
Nakayama 1996; Peters 2000; Stamler 1996; van Dijk 2012).
How the intervention might work
While the exact mechanisms through which dietary modifications
might act to prolong life expectancy and kidney function are likely
to bemultifactorial, there is emerging evidence showing the impact
of dietary changes on risk factors for kidney injury and cardiovas-
cular disease. In recent Cochrane reviews of dietary advice in pri-
mary and secondary prevention studies - predominantly through
reduction of salt and fat intake and increased fruit, vegetables, and
fibre intake - dietary changes reduced arterial blood pressure by up
to 10 mmHg on average, as well as serum cholesterol and sodium
excretion (Hartley 2013; Rees 2013a; Rees 2013b).
Combined dietary and exercise interventions among people at risk
of diabetes, many of whom have kidney disease, reduce weight
and body mass and have modest effects on blood lipids and blood
pressure, while altered carbohydrate or energy intake plus exercise
improves glycaemic control in people with type 2 diabetes (Nield
2008; Orozco 2008). Intensive advice and support to reduce salt
intake may have small and unsustained effects on blood pressure
(Adler 2014) of uncertain clinical importance. Among people at
high cardiovascular risk, a Mediterranean diet increases circulat-
ing anti-oxidant levels, which has been proposed as one possible
mechanism for improved survival (Zamora-Ros 2013). Whether
dietary alteration of risks factors for cardiovascular events includ-
ing blood pressure, serum lipids, or anti-oxidant levels modify
clinical outcomes for people with CKD remains uncertain.
Why it is important to do this review
Although numerous randomised controlled trials (RCTs) in peo-
ple with CKD have evaluated single nutrient management (such
as protein intake or salt intake), there is relatively less information
about the impact of whole dietary modifications - for example, the
Mediterranean diet or Dietary Approaches to Stop Hypertension
(DASH) diet - on clinical outcomes in people with CKD. Clinical
studies in this area have been largely restricted to modifying pro-
tein, sodium, and phosphorus dietary intake as well as antioxidant
supplementation (Fouque 2009; Jun 2012; Liu 2015; McMahon
2015). Among people with CKD, lowered dietary salt intake re-
duced blood pressure and the amount of protein excreted by the
kidney (an indicator of cardiovascular risk) (McMahon 2015), al-
though there was no high-quality evidence this translated to slower
kidney disease progression or fewer cardiovascular complications.
Although dietary interventions in the setting of CKD have com-
monly focused on protein restriction as a mechanism to slow kid-
ney failure, there is limited evidence that this dietary strategy is
effective and safe and the impact of different protein sources on
clinical outcomes is poorly understood (Robertson 2007; Fouque
2009).
Global clinical guidelines recommend dietary strategies in the
management of CKD (KDIGO 2012). Specifically, guidelines
suggest lower protein intakewith appropriate education and avoid-
ing high protein intake for people at risk of kidney disease progres-
sion, lower salt intake, and increased physical activity (aiming for
at least 30 minutes, 5 times/week). Guidelines recommend that
people with CKD receive dietary advice and information in the
context of an education program that is tailored to the severity
6Dietary interventions for adults with chronic kidney disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
of their CKD and the need to modify salt, phosphate, potassium,
and protein intake. Given these guidelines, up to date evidence of
the benefits and harms of dietary management is needed to inform
practice and policy.
In addition, patients, caregivers and health professionals consider
the effects of dietarymanagement as important and a priority treat-
ment uncertainty in CKD (Manns 2014). When speaking about
dietary changes, some patients experience dietary restrictions as an
intense and unremitting burden (Palmer 2015a), while at the same
time offering them greater self-efficacy in themanagement of their
CKD. In general, patients value better understanding of the role of
lifestyle management as a research priority (Tong 2015). Dietary
management is therefore an important potential intervention for
improving clinical outcomes in CKD that aligns with patient pri-
orities.
O B J E C T I V E S
This review evaluated the benefits and harms of dietary interven-
tions among adults with CKD including people with end-stage
kidney disease (ESKD) treated with dialysis or kidney transplan-
tation.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included RCTs and quasi-RCTs (in which allocation to treat-
ment was obtained by alternation, use of alternatemedical records,
date of birth, or other predictable methods) measuring the effect
of dietary interventions in adults with CKD.
Types of participants
Inclusion criteria
Adults with any stage of CKD (any structural kidney or urine ab-
normality with or without reduced glomerular filtration rate below
60 mL/min/1.73 m2 as defined by the Kidney Disease: Improving
Global Outcomes (KDIGO 2012)) including people with ESKD
treated with dialysis, kidney transplantation or supportive care.
Exclusion criteria
Pregnant women and children younger than 18 years.
Types of interventions
Inclusion criteria
We evaluated the following dietary modifications (including di-
etary advice or lifestyle management) compared with any other
dietary pattern or standard care (including lifestyle advice).
• Dietary patterns (e.g. DASH diet; Mediterranean diet,
American Heart Association diet)
• Nutritional counselling and education about food-based
dietary interventions
We included studies evaluating interventions for at least one
month and studies in which concomitant non-randomised inter-
ventions such as antihypertensive medication, sodium restriction,
or other co-interventions including supplements were used during
the study period (e.g. specific blood pressure targets), providing
that these interventions were administered to all treatment groups.
We included studies of dietary modifications regardless of whether
other dietary changes such as salt or phosphorus dietary intake
were adjusted. We did not include differing levels of energy intake
as interventions in the review.
Exclusion criteria
We excluded dietary interventions that were “single-nutrient” or
nutrient-focused interventions (including supplementation). This
included the following dietary management interventions.
• Dietary management of specific dietary factors including
sodium, phosphorus, and protein (as these are evaluated in other
Cochrane reviews (Fouque 2009; Jun 2012; Liu 2015;
McMahon 2015)
• Probiotics, prebiotics, or synbiotics
• Implementation strategies for dietary or lifestyle
management
Types of outcome measures
We categorised outcomes according to length of follow up (< 6
months and ≥ 6 months). We extracted and analysed data for
shorter (< 6 months) and longer (≥ 6 months) term outcomes
separately.
Primary outcomes
1. All-cause mortality
2. Major adverse cardiovascular events (as defined by study
investigators)
3. Health-related quality of life (as defined and measured by
investigators)
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Secondary outcomes
1. Withdrawal from dietary intervention
2. Cause-specific death (cardiovascular mortality, sudden
death, infection-related mortality)
3. Progression to ESKD (as defined by the investigators
including estimated glomerular filtration rate below 15 mL/min/
1.73 m2 or requiring treatment with long-term dialysis or kidney
transplantation)
4. Participant adherence to intervention
5. Myocardial infarction
6. Kidney function measures (creatinine clearance or
estimated glomerular filtration rate, doubling of serum
creatinine, serum creatinine)
7. Serum lipids (total cholesterol, low density lipoprotein
(LDL) cholesterol, triglycerides)
8. Blood pressure
9. Blood glucose control (glycated haemoglobin; fasting
plasma glucose)
10. Global measures of nutritional status (body mass index
(BMI); body weight; waist circumference; subjective global
assessment; malnutrition screening tool; mini nutritional
assessment; skin-fold measurements; bioelectrical impedance
analysis; albumin; prealbumin)
Search methods for identification of studies
Electronic searches
We searched the Cochrane Kidney and Transplant Specialised
Register (up to 31 January 2017) through contact with the Infor-
mation Specialist using search terms relevant to this review. The
Cochrane Kidney and Transplant Specialised Register contains
studies identified from several sources.
1. Monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL)
2. Weekly searches of MEDLINE OVID SP
3. Handsearching of kidney-related journals and the
proceedings of major kidney conferences
4. Searching of the current year of EMBASE OVID SP
5. Weekly current awareness alerts for selected kidney and
transplant journals
6. Searches of the International Clinical Trials Register
(ICTRP) Search Portal and ClinicalTrials.gov.
Studies contained in the SpecialisedRegister are identified through
search strategies for CENTRAL,MEDLINE, andEMBASE based
on the scope of Cochrane Kidney and Transplant. Details of these
strategies, as well as a list of handsearched journals, conference
proceedings and current awareness alerts, are available in the Spe-
cialised Register section of information about Cochrane Kidney
and Transplant.
See Appendix 1 for search terms used in strategies for this review.
Searching other resources
1. Reference lists of review articles, relevant studies and
clinical practice guidelines.
2. Letters seeking information about unpublished or
incomplete studies to investigators known to be involved in
previous studies.
Data collection and analysis
Selection of studies
The search strategywas used to obtain titles and abstracts of studies
thatmight have been relevant to the review. The titles and abstracts
were screened independently by at least two authors (SP and JM),
who discarded studies that were not eligible; however, studies and
reviews that might have included relevant data or information on
studies were retained initially. Two authors (SP and JM) indepen-
dently assessed retrieved abstracts and, if necessary the full text,
of these studies to determine which studies satisfied the inclusion
criteria. Any uncertainties about study eligibility were discussed
between authors and if necessary with a third author (KC).
Data extraction and management
Data extraction was carried out independently by two authors us-
ing pre-specified standard data extraction forms. Studies reported
in non-English language journals were electronically translated be-
fore assessment. Where more than one publication of one study
exists, study reports were grouped together and the publication
with the most complete data was used in the analyses. Where rel-
evant outcomes are only published in earlier publications of the
study, these data were used. Any discrepancy between published
versions were evaluated and highlighted.
Assessment of risk of bias in included studies
The following reporting items were independently assessed by two
authors (SP and JM) using the Cochrane risk of bias assessment
tool (Higgins 2011) (see Appendix 2):
• Was there adequate sequence generation (selection bias)?
• Was allocation adequately concealed (selection bias)?
• Was knowledge of the allocated interventions adequately
prevented during the study?
◦ Participants and personnel (performance bias)
◦ Outcome assessors (detection bias)
• Were incomplete outcome data adequately addressed
(attrition bias)?
• Are reports of the study free of suggestion of selective
outcome reporting (reporting bias)?
• Was the study apparently free of other problems that could
put it at a risk of bias? These were pre-specified as: baseline
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imbalance, interim reporting, deviation from study protocol in a
way that does not reflect clinical practice, pre-randomisation
administration of an intervention that could enhance or
diminish the effects of a subsequent randomised intervention,
contamination, occurrence of ’null bias’ due to interventions
being insufficiently well delivered or overly wide inclusion
criteria, selective reporting of subgroups, reporting of trial
registration, reporting of funding source(s), publication as full
journal report, and fraud.
Measures of treatment effect
For dichotomous outcomes (total and cause-specific mortality,
myocardial infarction, progression to ESKD, doubling of serum
creatinine, participant adherence, withdrawal from intervention),
the treatment effects of dietary management were expressed as
a risk ratio (RR) together with 95% confidence intervals (CI).
Where continuous scales of measurement are used to assess the
effects of dietary management (health-related quality of life, blood
pressure, lipids (total cholesterol, LDL cholesterol, triglycerides),
kidney function (serum creatinine, creatinine clearance, glomeru-
lar filtration rate), body composition (weight, waist circumference,
BMI)), the mean difference (MD) between treatment groups were
used, or the standardised mean difference (SMD) if different mea-
surement scales have been reported. A standardised mean differ-
ence of 0.2 indicated a small difference, 0.5 a moderate difference
and 0.8 a large difference. We evaluated mean end of treatment
values for continuous outcomes together with the reported stan-
dard deviation in meta-analyses for these continuous outcomes.
Unit of analysis issues
Studies with more than two interventions were evaluated in this
review. We used recommended methods for data extraction and
analysis described by theCochrane Collaboration (Higgins 2011).
Cross-over studies
There were no cross-over studies included in this meta-analysis.
Studies with more than two interventions
Studies with multiple intervention groups were included. When a
studywas a ’multi-arm’ study, and all treatment arms provided data
for eligible interventions, the study was described and included
in the systematic review. If there were adequate data from the
study, then treatment arms relevant to the treatment comparisons
of interest were included in applicable meta-analyses.
Cluster randomised studies
Weplanned to include information from cluster randomised stud-
ies. We planned to divide the effective sample size for each data
point by a quantity called the design effect calculated as 1 + (M
- 1) ICC, where M was the average cluster size and ICC was the
intra-cluster correlation coefficient. In this calculation, a common
design effect was assumed across all intervention groups. The in-
tra-cluster coefficient (ICC) is seldom available in published re-
ports. We therefore planned to adopt a common approach to use
external estimates obtained from similar studies. For dichotomous
outcomes, we planned to divide the number of participants and
the number experiencing the event by the design effect. For con-
tinuous endpoints only the sample size was planned to be divided
by the design effect with means and standard deviations remaining
unchanged.
Dealing with missing data
Any further information required from the original author was re-
quested by electronic mail and any relevant information obtained
in this manner was included in the review. Evaluation of impor-
tant numerical data such as screened, randomised patients as well
as intention-to-treat, as-treated and per-protocol population were
carefully performed. Attrition rates, for example drop-outs, losses
to follow-up and withdrawals were investigated. Issues of missing
data and imputation methods (for example, last-observation-car-
ried-forward) was critically appraised (Higgins 2011).
Assessment of heterogeneity
Statistical heterogeneity in treatment effects among studies was
analysed using a Chi² test on N-1 degrees of freedom, with an
alpha of 0.05 used for statistical significance and with the I² test
(Higgins 2003). We considered I² values of 25%, 50% and 75%
as corresponding to low, medium and high levels of heterogeneity.
Assessment of reporting biases
There were insufficient data to generate funnel plots to assess for
the potential existence of small study bias for the outcome of all-
cause mortality.
Data synthesis
We grouped studies by dietary modifications into similar inter-
ventions (e.g. counselling; Mediterranean; fruits and vegetables).
Treatment estimates for the specified were summarised within
groups of dietary modifications and treatment effects were sum-
marised using random-effects meta-analysis. Effects were reported
as the relative risk (RR) and 95% confidence interval (CI) for bi-
nary outcomes and mean difference (MD) and 95% CI for con-
tinuous outcomes.
We summarised information for outcomes in which meta-analysis
is not possible due to insufficient observations using narrative ta-
bles. Narrative outcome reporting included health-related quality
of life domains described in the studies and nutrition assessments.
The dietary interventions and associated implementation strate-
gies were described using the “Better reporting of interventions:
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Template for Intervention Description and Replication (TIDieR)
checklist and guide” (Hoffmann 2014) and tabulated in the re-
view.
Subgroup analysis and investigation of heterogeneity
There were insufficient extractable data to conduct subgroup and
univariate meta-regression analysis to explore the following vari-
ables as possible sources of heterogeneity: mean study age, mean
proportion of men, energy intake, study-level mean blood pres-
sure or cholesterol at baseline, proportion with diabetes, adequacy
of allocation concealment, sample size, and duration of follow up
(< 12 months versus ≥ 12 months).
Sensitivity analysis
There were insufficient extractable data to perform the following
sensitivity analyses in order to explore the influence of the follow-
ing factors on effect size:
• Repeating the analysis excluding unpublished studies
• Repeating the analysis taking account of risk of bias, as
specified above
• Repeating the analysis excluding any very long or large
studies to establish how much they dominated the results
• Repeating the analysis excluding studies using the following
filters: diagnostic criteria, language of publication, source of
funding (industry versus other), and country.
’Summary of findings’ tables
We presented the main results of the review in a ’Summary of
findings’ table for the outcomes of all-cause mortality, cardiovas-
cular mortality, ESKD, and health-related quality of life. ’Sum-
mary of findings’ tables present key information concerning the
quality of the evidence, the magnitude of the effects of the in-
terventions examined, and the sum of the available data for the
main outcomes (Schunemann 2011a). The ’Summary of findings’
tables also included an overall grading of the evidence related to
each of the main outcomes using the GRADE (Grades of Recom-
mendation, Assessment, Development and Evaluation) approach
(GRADE 2008). The GRADE approach defines the quality of
a body of evidence as the extent to which one can be confident
that an estimate of effect or association is close to the true quan-
tity of specific interest. The quality of a body of evidence involves
consideration of within-trial risk of bias (methodological quality),
directness of evidence, heterogeneity, precision of effect estimates
and risk of publication bias (Schunemann 2011b).
R E S U L T S
Description of studies
Results of the search
The electronic search strategy of the Cochrane Kidney and Trans-
plant SpecialisedRegister (31 January 2017) identified 824 records
(Figure 1). After initial title and abstract screening, 754 records
were excluded. The full-text of the remaining 70 records were eval-
uated. A further 47 records were excluded (21 were not in people
with CKD, 25 were not evaluating dietary patterns, three were
not randomised).
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Figure 1. Flow diagram of study selection
Seventeen studies (21 records) were included, one study was ex-
cluded, and one ongoing study was identified and will be assessed
in a future update of this review.
Included studies
See Characteristics of included studies.
Overall, 17 studies reported in 21 publications involving 1639
people with CKD were eligible (Campbell 2008; Chanwikrai
2012;DIRECT Study 2013; Facchini 2003; Flesher 2011;Goraya
2013;Goraya 2014; Leon 2006;Mekki 2010;Orazio 2011; Riccio
2014; Stachowska 2005; Sutton 2007; Teng 2013; Tzvetanov
2014; Whittier 1985; Zhou 2011b). The study characteristics are
summarised in Table 1. Studies were published between 2003 and
2014, with all but five (Facchini 2003; Leon 2006; Stachowska
2005; Sutton 2007; Whittier 1985) of the studies published since
2008.
Three studies enrolled 341 people treated with long-term dialysis
(haemodialysis (1), peritoneal dialysis (2)), four studies enrolled
168 kidney transplant recipients, and 10 studies enrolled 1130
people with CKD stages 1 to 5.
In the studies involving people with CKD, the average eGFR
ranged between 21.6 and 75 mL/min/1.73 m2. Most participants
with CKD had an eGFR < 60 mL/min/1.73 m2.The mean study
eGFR ranged between 22.8 and 70 mL/min/1.73 m2. In kidney
transplant recipients, the eGFR at baseline in the two studies re-
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porting this was between 48 and 54 mL/min/1.73 m2.
Studies had generally small sample sizes (median 73 participants,
range 12 to 318 patients). Participants were followed up for be-
tween one month and 3.9 years (median 12 months).
Thirteen studies that reported funding received funding from gov-
ernmental or healthcare organisations, and four studies did not
report their funding source.
Studies were conducted in Algeria (Mekki 2010), Australia
(Campbell 2008; Orazio 2011), Canada (Flesher 2011), China
(Zhou 2011b), Israel (DIRECT Study 2013), Italy (Riccio
2014), Poland (Stachowska 2005), Taiwan (Teng 2013), Thailand
(Chanwikrai 2012), theUK (Sutton 2007), and theUSA (Facchini
2003; Goraya 2013; Goraya 2014; Leon 2006; Tzvetanov 2014;
Whittier 1985).
The mean age in the included studies ranged between 41 years
(Stachowska 2005) and 69.5 years (Campbell 2008). The mean
BMI at baseline ranged between 22.8 and 38.6 kg/m2(median
28.5 kg/m2).
Dietary interventions
The methods for dietary implementation, tailoring, and measure-
ment of adherence are provided in Table 2 and reported using
a Template for Intervention Description and Replication (TIDieR)
checklist (Hoffmann 2014).
Dietary interventions includeddietary counsellingwith orwithout
physical activity and lifestyle advice in 10 studies (860participants)
(Campbell 2008; Chanwikrai 2012; Flesher 2011; Leon 2006;
Orazio 2011; Riccio 2014; Sutton 2007; Teng 2013; Tzvetanov
2014; Zhou 2011b), a Mediterranean diet in three studies (395
participants) (DIRECT Study 2013; Mekki 2010; Stachowska
2005), increased fruit and vegetable intake in two studies (179
participants) (Goraya 2013; Goraya 2014), a carbohydrate-re-
stricted, low-iron available, polyphenol enriched (CR-LIPE) diet
in Facchini 2003 (191 participants), and a high protein/low carbo-
hydrate diet in Whittier 1985 (12 participants). A high fruit and
vegetable intake was compared with oral bicarbonate supplemen-
tation in the setting of CKD. AMediterranean diet was compared
with a control diet, a low fat diet, or a low carbohydrate diet. In
general, dietary modifications tended to include increased intake
of fish and poultry, fruit and vegetables, olive oil, and nuts, and
lower intake of carbohydrates, red meat, sodium, and sugars.
The aims of the dietary counselling studies were generally to
assess whether dietary advice could improve nutritional status
and body composition (Campbell 2008; Zhou 2011b), slow pro-
gression of CKD (Chanwikrai 2012; Flesher 2011), or decrease
biochemical derangement in kidney disease (Riccio 2014; Teng
2013). Studies of dietary patterns were primarily aimed at assess-
ing effects of dietary intake on kidney function (DIRECT Study
2013; Facchini 2003; Goraya 2013; Goraya 2014) or dyslipi-
daemia (Mekki 2010). Among people treated with dialysis, the in-
terventions were aimed at increasing serum albumin levels (Leon
2006), supporting adjusted energy intake (Sutton 2007), and im-
proving under nutrition (Zhou 2011b). Dietary interventions for
transplant recipients aimed to modify cardiovascular risk factors
(Orazio 2011; Stachowska 2005), provide lifestyle advice includ-
ing nutrition guidance (Tzvetanov 2014), or reduce cushingoid
side-effects.
Two studies reported three treatment groups. In DIRECT Study
2013, a calorie-restricted Mediterranean diet was compared with
a calorie-restricted low-fat diet or calorie-unrestricted low-carbo-
hydrate diet. In Goraya 2014, increased fruit and vegetable intake
was compared with oral bicarbonate supplementation and stan-
dard care.
Excluded studies
The one study which meet our population and intervention cri-
teria was excluded as it was only for a short duration (10 days)
(Parillo 1988).
Risk of bias in included studies
See Figure 2; Figure 3 for summary of ’Risk of bias’ assessments.
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Reporting of details of study methodology was incomplete for
most studies. The summary risks of bias are shown in Figure 2 and
risk of bias in each individual study is shown in Figure 3.
Allocation
Random sequence generation
Three studies reported adequate (low risk) random sequence gen-
eration (Campbell 2008; Leon 2006; Sutton 2007). The risk of
bias from random sequence generation methods was unclear in
the remaining 14 studies.
Allocation concealment
Only Campbell 2008 was judged to have adequate allocation con-
cealment (low risk). Risks from allocation concealment was un-
clear in the remaining 16 studies.
Blinding
Performance bias
Dues to the nature of the interventions, performance bias was
judged as high risk in all 17 studies.
Detection bias
Detection bias was judged to be low risk in DIRECT Study 2013
and high in Zhou 2011b. Risk of detection bias was unclear in the
remaining 15 studies.
Incomplete outcome data
Attrition bias was low risk in seven studies (Campbell 2008;
Chanwikrai 2012; DIRECT Study 2013; Facchini 2003; Flesher
2011; Teng 2013; Zhou 2011b) and high risk in three studies
(Leon 2006; Sutton 2007; Tzvetanov 2014). Risks from attrition
bias were unclear in the remaining seven studies.
Selective reporting
Three studies were at low risk of reporting bias (Campbell 2008;
Facchini 2003; Flesher 2011), and the remaining 14 studies were
at high risk of reporting bias.
Other potential sources of bias
Eight studies were judged to be at low risk of other potential
biases (Campbell 2008; Flesher 2011; Goraya 2013;Goraya 2014;
Mekki 2010;Orazio 2011;Teng 2013;Whittier 1985); five studies
were judged to be high risk of bias (Chanwikrai 2012; DIRECT
Study 2013; Leon 2006; Riccio 2014; Stachowska 2005), and risks
of bias were unclear in four studies (Facchini 2003; Sutton 2007;
Tzvetanov 2014; Zhou 2011b).
Effects of interventions
See: Summary of findings for the main comparison Dietary
modifications (counselling or dietary change) versus control for
chronic kidney disease (CKD)
Data for health-related quality of life are shown in Table 3. Adverse
event data are reported in Table 4. Adverse events were rarely
reported.
Primary outcomes
No included studies were designed to examine effects of dietary in-
terventions on all-cause mortality or major cardiovascular events.
The confidence in the results for these outcomes was very low.
All-cause mortality
Five studies (Campbell 2008; Facchini 2003; Flesher 2011; Leon
2006; Sutton 2007) reported the number of deaths. Of these,
four studies (Campbell 2008; Flesher 2011; Leon 2006; Sutton
2007) reported deaths as part of the information provided about
participant recruitment or attrition from study follow-up which
lasted between 12 weeks and 12 months. Dietary counselling had
uncertain effects on all-cause mortality (Analysis 1.1.1 (4 studies,
371 participants): RR 1.59, 95% CI 0.60 to 4.21; I2 = 0%).
In one study comparing a low-iron-available, polyphenol enriched
carbohydrate-restricted (CR-LIPE) dietwith control over 3.9 years
(Facchini 2003), mortality was reported as a patient outcome. A
CR-LIPE diet had uncertain effects on all-cause mortality com-
pared with standard care (Analysis 1.1.2 (1 study, 170 partici-
pants): RR 0.50, 95% CI 0.22 to 1.12). The confidence in the ev-
idence for all-cause mortality was very low (Summary of findings
for the main comparison).
Major adverse cardiovascular events
Campbell 2008 death from cardiovascular causes was described
by investigators when reporting study loss to follow-up during the
12 month study. Dietary counselling had very uncertain effects on
cardiovascular mortality (Analysis 1.2.1 (1 study, 62 participants):
15Dietary interventions for adults with chronic kidney disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
RR 6.58, 95%CI 0.35 to 122.21). The confidence in the evidence
for cardiovascular events was very low (Summary of findings for
the main comparison).
Health-related quality of life
Only six studies included quality of life measures (Table 3). Of
these, four studies used the Kidney Disease Quality of Life ques-
tionnaire and/or the Short Form-36 (Campbell 2008; Leon 2006;
Tzvetanov 2014; Zhou 2011b). In two studies (Tzvetanov 2014;
Zhou 2011b), dietary counselling was associated with a higher
score on the SF-36 questionnaire than standard care (Analysis
1.3.1 (2 studies, 119 participants): MD 11.46, 95% CI 7.73 to
15.18; I2 = 0%). The confidence in the evidence for health-re-
lated quality of life was low (Summary of findings for the main
comparison).
Secondary outcomes
End-stage kidney disease
No included studies were designed to examine ESKD or risks of
doubling of serum creatinine. The confidence in the results for
ESKD was very low. Two studies reported the number of partic-
ipants experiencing ESKD (Campbell 2008; Facchini 2003). In
one of these studies comparing dietary counselling with standard
care, the number of people starting dialysis was reported as part
of participant progression in the 12-week study (Campbell 2008).
In one study, a CR-LIPE diet had uncertain effects on ESKD
compared with standard care. In the two studies combined, di-
etary interventions did not have statistically significant effect on
risks of ESKD ((Analysis 1.4 (2 studies, 232 participants): RR
0.53, 95% CI 0.26 to 1.07; I2 = 0%). The confidence in the evi-
dence for ESKD was very low (Summary of findings for the main
comparison).
Doubling of serum creatinine
Facchini 2003 reported that a CR-LIPE diet was associated with
lower risks of doubling of serum creatinine ((Analysis 1.5 (1 study,
170 participants): RR 0.53, 95% CI 0.33 to 0.86).
Employment
Dietary counselling had uncertain effects on employment during
a single 12month study involving recipients of a kidney transplant
(Analysis 1.6 (1 study, 17 participants): RR 6.22, 95% CI 0.96 to
40.22).
Dietary adherence
Dietary counselling had uncertain effects on dietary adherence
compared with standard care, in a single study (Analysis 1.7 (1
study 54 participants): RR 1.58, 95% CI 0.97 to 2.58).
Worsening nutrition
In two studies, the proportion of participants with worsening nu-
tritional status was measured using subjective global assessment
(SGA) (Campbell 2008; Leon 2006). Compared with usual care,
dietary counselling had uncertain effects on nutritional status as
measured by SGA (Analysis 1.8.1 (2 studies, 230 participants):
RR 0.40, 95% CI 0.05 to 3.37; I2 = 57%).
Kidney function
eGFR
Dietary intervention was associated with a higher eGFR (Analysis
1.9 (5 studies, 219 participants): SMD1.08; 95%CI 0.20 to 1.97;
I2 = 88%) than standard care, although there was verymarked het-
erogeneity in treatment effects between the four studies evaluating
dietary counselling and this may have been due to the different
strategies used in participant counselling.
Fruits and vegetables had uncertain effects on the eGFR compared
with oral bicarbonate supplementation (Analysis 3.1 (2 studies,
143 participants); MD 0.84 mL/min/1.73 m2, 95% CI -0.84 to
2.53; I2 = 0%).
Serum creatinine
Dietary interventions had uncertain effects on serum creatinine
when compared to control (Analysis 1.10 (3 studies 112 partici-
pants): MD 0.83 µmol/L, 95% CI -16.57 to 18.23; I2 = 0%).
In Goraya 2013, fruits and vegetables had very uncertain effects
on serum creatinine compared with oral bicarbonate supplemen-
tation (Analysis 3.2 (1 study, 71 participants): MD -9.00 µmol/
L, 95% CI -39.11 to 21.11).
Blood pressure
Systolic blood pressure
Dietary interventions lowered systolic blood pressure compared
with standard care (Analysis 1.11 (3 studies, 167 participants):
MD -9.26 mm Hg, 95% CI -13.48 to -5.04; I2 = 80%). There
was heterogeneity in the effects between the two different dietary
approaches (I2=88.7%).
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Fruits and vegetables lowered systolic blood pressure compared
to oral bicarbonate supplementation (Analysis 3.3 (2 studies, 143
participants):MD-5.81mmHg, 95%CI -8.84 to -2.77) although
there was high heterogeneity between studies (I2 = 79%).
Diastolic blood pressure
Dietary counselling lowered diastolic blood pressure compared
with standard care (Analysis 1.12 (2 studies, 95 participants): MD
-8.95 mm Hg, 95% CI -10.69 to -7.21; I2 = 0%)
Energy intake
Different dietary interventions had statistically heterogeneous ef-
fects on energy intake and therefore the results of all available di-
etary approaches compared with standard care were not combined
within a single analysis.
Dietary counselling had uncertain effects on energy intake com-
pared to standard care (Analysis 1.13.1 (4 studies, 340 partici-
pants); SMD 1.54, 95% CI -0.87 to 3.95). There was very high
heterogeneity in this analysis (I2 = 99%) likely due to the differing
counselling approaches in the included studies.
A Mediterranean diet was associated with higher energy intake
than standard care in Mekki 2010 (Analysis 1.13.2 (1 study, 40
participants): SMD 1.86, 95% CI 1.11-2.61).
A high nitrogen and low carbohydrate diet had uncertain effects
on energy intake in Whittier 1985 (Analysis 1.13 (1 study, 12
participants): SMD -0.65, 95% CI -1.82 to 0.53).
Body weight, BMI, waist circumference, waist-to-hip ratio
and arm circumference
Body weight
Dietary interventions had uncertain effects on body weight com-
pared with control (Analysis 1.14 (6 studies, 454 participants):
MD -0.44 kg, 95% CI -1.46 to 0.58; I2 = 15%).
A higher fruit and vegetable intake was associated with a lower
body weight than oral bicarbonate supplementation (Analysis 3.4
(2 studies, 143 participants):; MD -5.09 kg, 95% CI -7.73 to -
2.44; I2 = 56%).
BMI
Dietary interventions had uncertain effects on BMI compared
with control (Analysis 1.15 (2 studies, 119 participants): MD -
1.70 kg/m2, 95% CI -5.23 to 1.82; I2 = 14%).
Waist-to-hip ratio, waist circumference, and arm
circumference
In Orazio 2011, dietary interventions had uncertain effects on
waist-to-hip ratio compared with control (Analysis 1.16 (1 study,
82 participants): MD -1.05, 95% CI -5.92 to 3.82). In the same
study, dietary interventions had uncertain effects on the waist cir-
cumference (Analysis 1.17 (1 study, 82 participants): MD -0.46
cm, 95% CI -2.05 to 1.13).
Dietary interventions had uncertain effects on arm circumference
comparedwith control (Analysis 1.18 (2 studies, 149participants):
MD 0.37 cm, 95% CI -0.39 to 1.12; I2 = 0%).
Serum albumin
Dietary interventions increased serum albumin levels compared
with control (Analysis 1.19 (6 studies, 541 participants): MD 0.16
g/dL, 95% CI 0.07 to 0.24; I2 = 26%).
Serum LDL cholesterol
In Mekki 2010, a Mediterranean diet lowered serum LDL choles-
terol levels compared with a control diet (Analysis 1.20.1 (1 study,
40 participants): MD -1.00 mmol/L, 95% CI -1.56 to -0.44).
In Facchini 2003, a CR-LIPE diet had uncertain effects on serum
LDL cholesterol levels compared with a control diet (Analysis
1.20.2 (1 study, 148 participants): MD 0.21 mmol/L, 95% CI -
0.38 to 0.81).
In Stachowska 2005, a Mediterranean diet lowered serum LDL
cholesterol levels compared with a low fat diet (Analysis 2.1 (1
study, 38 participants): MD -0.60 mmol/L, 95% CI -1.15 to -
0.05).
Investigation of publication bias, sub-group analyses and
sensitivity analyses
Investigation of publication bias, sub-group analyses and sensitiv-
ity analyses were not possible due to a lack of data observations. In
particular there were insufficient data observations to test whether
effects of dietary interventions were modified by stage of kidney
disease.
D I S C U S S I O N
Summary of main results
This review summarises 17 studies of dietary interventions in-
volving 1639 people with CKD that took place in a wide variety
of global regions and health systems. Dietary interventions were
evaluated for a median of 12 months. Dietary interventions were
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counselling, or a dietary pattern (Mediterranean; low fat; low car-
bohydrate; high fruit and vegetable; carbohydrate-restricted, low-
iron available, polyphenol-enriched; low carbohydrate-high nitro-
gen) compared with standard care, low protein intake, low fat
or low carbohydrate intake, or oral bicarbonate supplementation.
The studies included people with stages 1-5 CKD, kidney trans-
plant recipients, and people with ESKD requiring dialysis. There
was considerable heterogeneity in dietary interventions and their
implementation, together with differences in tailoring of dietary
management to individual requirements and methods to support
adherence. Risks of bias in the included studies were often high
or unclear, and these risks combined with imprecision in effect
estimates led to low or very low confidence in the results.
Studies were not designed to assess dietary effects on risks of death
or cardiovascular events. As a result there was considerable uncer-
tainty about the effects of dietary approaches on these outcomes
including risks of myocardial infarction or stroke. This finding
is particularly relevant as many people with CKD will die from
cardiovascular causes before requiring treatment with dialysis or
kidney transplantation.
Dietary effects on health-related quality of life were infrequently
reported and were documented using different tools, limiting the
ability of studies to be combined. In low quality evidence, dietary
interventions may have clinically-important increases in the SF-
36 quality of life score. There was evidence that dietary modifica-
tion impacted risks of ESKD, although dietary interventions may
increase GFR compared with standard care. Dietary interventions
lowered systolic and diastolic blood pressure by nearly 10 mmHg
on average and increased serum albumin levels.
Overall, these data suggest that current evidence for dietary in-
terventions in the setting of CKD is of very low quality and in-
sufficient to guide clinical practice. Possible beneficial effects of
dietary modifications on risk factors for disease in this review, the
association of healthy eating patterns with lower mortality in non-
randomised studies (Chen 2016; Gutierrez 2014;Muntner 2013),
and the priority placed on dietary restrictions in research (Tong
2015a) suggest dietary interventions remain an important research
and clinical uncertainty in the setting of kidney disease.
Overall completeness and applicability of
evidence
The strengths of this review comprehensive systematic searching
for eligible studies, rigid inclusion criteria for RCTs, and data ex-
traction and analysis by two independent investigators. We aimed
to evaluate the effectiveness of dietary modification for range of
food groups for people with CKD. This review included a small
number of studies with heterogeneous interventions and imple-
mentation strategies. We could not robustly assess the effect of
dietary pattern on endpoints such as mortality or cardiovascular
events in people with CKD as there were few studies of sufficient
size or duration to examine these outcomes. Despite preliminary
evidence for improved blood pressure and serum cholesterol with
some dietary patterns, evidence for the longer-term effects of di-
etary pattern on patient-level outcomes remains to be determined.
There was a lack of consistency in estimating health-related quality
of life among the available studies. Given the patients report di-
etary requirements and restrictions as a sometimes intense burden
(Palmer 2015a), this aspect of dietary interventions remains im-
portant for future exploration. Reporting of health-related quality
of life using tools validated for CKD would be helpful in future
research studies.
Quality of the evidence
We assessed the quality of study evidence using standard risks of
bias domains within the Cochrane tool together with GRADE
methodology. Confidence in evidence for all-cause mortality, ma-
jor cardiovascular events and health-related quality of life was very
low or could not be estimated, meaning future studies might offer
different results. No study had low risk methods for allocation
concealment and none of the participants or study investigators
was masked to treatment allocation. We downgraded for the pos-
sibility of publication bias due to the very low numbers of data
observations for each outcome, precluding formal testing.
Data summary was also difficult due to the variable methods of
reporting in the individual studies. Particularly relevant was the
heterogeneous manner of reporting GFR and serum creatinine
concentrations. Some studies did not report an estimate of variance
(SE or SD) and some provided data in descriptive or figure format
only.
Potential biases in the review process
Potential biases in this review relate to the data availability in the
individual studies. First, there was heterogeneity in treatment in-
terventions and comparisons; due to the small number of data ob-
servations, robust statistical estimates of heterogeneity could not
be estimated. Second, we could not assess for potential reporting
bias due to the small number of studies in the review. Third, while
most participants had moderate CKD (stage 3 or 4), there was
wide variation in the definition of kidney disease for inclusion in
eligible studies. Fourth, studies were frequently at high risks of
bias, but poorer quality studies could not be excluded from sen-
sitivity analyses due to the limited number of data observations.
Fifth, the treatment endpoints were principally surrogate mark-
ers of health (blood pressure, serum cholesterol, serum albumin)
and the effects of dietary interventions on longer term outcomes
remains uncertain. Sixth, adverse event reporting in the available
studies was infrequent and inconsistent. Finally, selective outcome
reporting was a limitation across the included studies.
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Agreements and disagreements with other
studies or reviews
A recently publishedCochrane review (McMahon 2015) evaluated
salt restriction among patients with CKD. While the intervention
decreased blood pressure, as in this review there were insufficient
data available to assess the impact of salt restriction on all-cause
mortality or cardiovascular mortality. Similarly, in a Cochrane re-
view of dietary interventions for mineral and bone disorder in
CKD, there was low quality evidence that calcium enriched bread
might influence biochemical parameters, and data were insuffi-
cient to identify treatment effects on clinical outcomes including
cardiovascular mortality and fracture (Liu 2015). In a Cochrane
review of low protein diets among people with CKD, a delay
in progression of CKD was observed with a low protein intake
(Fouque 2009). A recent meta-analysis of eight non-randomised
of eating patterns among 15,285 people with CKD, healthy eating
was associated with lower risks of all-cause mortality (RR 0.73,
95% CI 0.63 to 0.83), but no effect on ESKD was detected (per-
sonal communication). The possible reasons for differences be-
tween the findings of that review and the present meta-analysis
could include the non-randomised nature of the data, with the
possibility of residual confounding accounting for the results, or
a larger sample size providing greater statistical power to observe
differences between treatment groups. A non-randomised study
conducted in the general population reported a dietary pattern
rich in whole grains, fruit, and low-fat dairy foods was associated
with lower urinary albumin to creatinine ratio (Nettleton 2008).
Albumin to creatinine ratio is used as a proxy marker for possi-
bility of development of kidney disease in the general population
and is also suggestive of increased risk of cardiovascular disease in
patients with diabetes and hypertension. The finding that a study
in this review showing a diet pattern with lower red meat and car-
bohydrates and higher olive oil content was associated with lower
risks of kidney failure suggests larger studies evaluating dietary
patterns on progression of CKD are clinically relevant.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Overall, these data suggest that current evidence for dietary inter-
ventions in the setting of CKD is of very low quality and insuffi-
cient to guide clinical practice. Possible beneficial effects of dietary
interventions include clinically-important increases in health-re-
lated quality of life, lower blood pressure and serum LDL choles-
terol levels and higher kidney function and serum albumin lev-
els. These preliminary findings represent potential mechanisms for
benefit of dietary modifications in larger studies, but the longer
term impact of dietary changes need to be examined.
Due to variation in dietary implementation and content, the range
of clinical settings in the studies, and the lack of evidence for clin-
ical outcomes, specific dietary recommendations or counselling
cannot be currently recommended in the care of CKD or people
treated with dialysis or a kidney transplant. As patients report di-
etary changes to be frequently confronting and intrusive and chal-
lenging to implement, patient input into future study design could
strengthen the quality and acceptability of tested interventions.
Not all areas of the world have health systems where dietitians
are able to provide patient-centred care or patients have access to
food types used in the studies in this review, and food availability
and health service funding might be important barriers to future
clinical studies.
Implications for research
Questions remain about the impact of dietary patterns on long-
term clinical outcomes in the setting of CKD. Dietary restrictions
are a priority uncertainty in CKD for patients and clinicians. This
review highlights potential intermediary mechanisms (lowering
blood pressure or serum cholesterol) through which dietary coun-
selling or specific dietary patterns might act to benefit long-term
health outcomes among people with CKD.
Given existing non-randomised studies suggest benefits of healthy,
plant-based dietary patterns on lowering mortality in CKD (Chen
2016; Gutierrez 2014), and large RCTs show the Mediterranean
diet lowers cardiovascular complications among people at risk of
cardiovascular disease (Estruch 2013), further research is needed to
evaluate the impact of dietary patterns on hard clinical outcomes
including mortality and cardiovascular endpoints in CKD.Quali-
tative data are available about the impact of dietary restrictions on
patient well-being (Palmer 2015a) that might be considered when
designing dietary strategies and their implementation. Given that
existing studies have generally small sample sizes and insufficient
power to determine effects on mortality and cardiovascular events,
consideration of a pragmatic study design to ensure efficient par-
ticipant recruitment, such as a registry-trial design, might assist
with study feasibility and cost.
Future research should pay specific attention to outcomes that
have been relatively under-researched, but are important causes
of significant morbidity. Due to the considerably higher risk of
death and cardiovascular events compared to ESKD, future stud-
ies should be powered to assess dietary effects on these outcomes.
We plan to add these to the review outcomes in future review up-
dates if they become available. There were no studies incorporat-
ing economic analyses; we suggest future studies should include
analyses of the relative costs and benefits of dietary management.
Dietary studies involving participants in resource-constrained set-
tings should be considered.
Given the variation in outcome measures routinely collected and
reported in nephrology studies including studies in the present
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review, a core (minimum) data set, such as that being generated
by the SONG collaboration (Tong 2015b), together with a vali-
dated measure of health-related quality of life would facilitate de-
velopment of clinically-relevant studies and useful meta-analyses
of dietary interventions.
Future studies in this area would benefit from drawing on a frame-
work for studies of complex interventions, which explicitly re-
quires theoretical modelling between processes and outcomes in
the pre-trial stage, and a process evaluation of the study (Anderson
2008). All studies should provide greater description of inter-
vention and standard models of care being assessed (Hoffmann
2014) and include process evaluations of how they are being im-
plemented (Moore 2014), using reporting guidelines for complex
interventions.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Campbell 2008
Methods • Study design: parallel RCT
• Recruitment: September 2004 to September 2005.
• Duration: 12 weeks
Participants • Country: Australia
• Setting: single centre (predialysis clinic)
• Inclusion criteria: adults with CKD and GFR < 30 mL/min; absence of
communication or intellectual impairment.
• Number: treatment group (31); control group (29)
• Mean age ± SD (years): treatment group (69.5 ± 11.7); control group (70.9 ± 11.
6)
• Sex (M/F): treatment group (17/12); control group (17/10)
• Baseline characteristics
◦ Mean baseline BMI (kg/m2): treatment group (26.8 ± 4.7); control group
(27.6 ± 5.2)
◦ Mean baseline SCr (mg/dL): treatment group (2.9 ± 1.0); control group (3.0
± 0.9)
◦ Mean baseline GFR (mL/min/1.73 m2): treatment group (23.1 ± 7.2);
control group (21.6 ± 6.1)
◦ Mean baseline serum albumin (g/dL): treatment group (3.9 ± 0.5); control
group (3.9 ± 0.4)
◦ Mean baseline calorie intake (kJ/kg): treatment group (101.8 ± 23); control
group (108.5 ± 25.2)
• Exclusion criteria: previously seen by dietitian for Stage IV CKD and
malnutrition due to conditions other than CKD
Interventions Treatment group
• Single dietitian administered intervention over 12 weeks, intervention was based
on nutrition therapy framework from the ADA. The intervention utilised self-
management principles (goal setting, menu planning, label reading and identification
of foods containing protein, sodium etc, depending on requirements) and was
individualised to each participant (including energy 125 to 146 KJ/kg/d and protein 0.
75 to 1 g/kg/d), incorporating KDOQI recommendations to provide intensive
nutritional counselling with regular monitoring
• Initial individual consultation was provided by dietitian, and then patients were
regularly monitored by telephone consultation, fortnightly for the first month, then
monthly
• Duration: 12 weeks
Control group
• Participants received generic nutrition information (as provided in regular clinical
practice) containing an overview of nutrition advice for CKD and co-morbidity
management
• No individualised advice or monitoring was provided
• Duration: 12 weeks
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Co-interventions
• Not reported
Outcomes Dietary intake was assessed by using a 3-day food record. Participants were requested to
estimate or measure all food and fluids consumed during those 3 days (2 weekdays and
1 weekend day). Food records were verified by the dietitian with visual food models and
household measures to ensure accuracy
• Body composition using total-body potassium counting (a measure of body cell
mass)
• Kidney death
• Quality of life
• Change in energy intake
• Change in protein intake
• Change in body cell mass
• Weight
• eGFR
• Serum albumin
• CRP
Notes • Funding source: Royal Brisbane and Women’s Hospital Foundation Seeding grant,
Queensland University of Technology Postgraduate Research Award (PhD scholarship)
, and an Institute of Health and Biomedical Innovation Research Scholarship
• Additional data: none requested
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated number sequence
Allocation concealment (selection bias) Low risk “Concealed to the recruiting officer”.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel not
reported in the study report. Participants
were randomised to individualised nutri-
tional counselling or written educationma-
terial. Therefore, the study was unlikely to
be blinded
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Insufficient information to permit judge-
ment
Incomplete outcome data (attrition bias)
All outcomes
Low risk All patient outcome data reported
Selective reporting (reporting bias) Low risk All expected outcomes reported
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Other bias Low risk Study appears free of other biases
Chanwikrai 2012
Methods • Study design: parallel RCT
• Time frame: not reported
• Duration: 12 weeks
Participants • Country: Thailand
• Setting: not reported
• Inclusion criteria: adult patients with stage 3 to 5 CKD
• Number: treatment group 1 (28); treatment group 2 (26); control group (27)
• Mean age ± SD (years): not reported
• Sex (M/F): not reported
• Baseline characteristics
◦ Mean body weight (kg): treatment groups (62.8); control group (56.0)
◦ Mean SCr (units); not reported
◦ Baseline GFR (units); not reported
◦ Mean baseline serum albumin (g/dL): not reported
◦ Mean baseline calorie intake (kcal): not reported
• Exclusion criteria: not reported
Interventions Control group
• Details regarding standard care not reported. Non-supplement group
Treatment group 1
• Diet managed
◦ Advised to consume low protein (0.6 to 0.8 g/kg/d) and low salt (5 g/d) diet
◦ Participated in empowerment activities: details not provided
Treatment group 2
• Diet plus exercise managed
◦ Advised to consume low protein (0.6 to 0.8 g/kg/d) and low salt (5 g/d) diet
◦ Advised to exercise
◦ Participated in empowerment activities: details not provided
Co-interventions
• None reported
Outcomes • SCr
• BUN
• Serum albumin
• Urine sodium
• SBP and DBP
Notes • Funding source: not reported
• Additional data: none requested
• Abstract-only publication
• Trial registration number not reported
Risk of bias
27Dietary interventions for adults with chronic kidney disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Chanwikrai 2012 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit judge-
ment
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel not
reported in the study report. Participants
were randomised to either control group,
diet only or diet and exercise group. There-
fore, the study was unlikely to be blinded
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Insufficient information to permit judge-
ment
Incomplete outcome data (attrition bias)
All outcomes
Low risk 96% of the participants completed study
and probably equal numbers in each group
completed study intervention
Selective reporting (reporting bias) High risk No pre-published study protocol. Unclear
whether treatment outcomes were reported
as planned. Clinical outcomes including
mortality and ESKD not reported
Other bias High risk Insufficient reporting information to fully
adjudicate risk. Published only as confer-
ence proceeding. Funding source(s) not
provided. Trial registration not provided
DIRECT Study 2013
Methods • Study design: parallel RCT
• Time frame: July 2005 and June 2007
• Duration: 24 months
Participants • Country: Israel
• Setting: single centre
• Inclusion criteria: Adults aged 40 to 65 years with BMI ≥ 27kg/m2, type 2
diabetes or coronary heart disease
• Number: treatment group 1 (102); treatment group 2 (108); treatment group 3
(108)
• Mean age ± SD (years): treatment group 1 (50.1± 6.4); treatment group 2 (50.8 ±
6.4); treatment group 3 (52.4 ± 6.2)
• Sex (M/F): treatment group 1 (87/15); treatment group 2 (98/10); treatment
group 3 (87/21)
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• Baseline characteristics
◦ Mean BMI (kg/m2): treatment group 1 (30.6 ± 3.2); treatment group 2 (30.
8 ± 3.5); treatment group 3 (31.2 ± 4.1)
◦ Mean baseline SCr level (mg/dL): not reported
◦ Mean baseline GFR (mL/min/1.73 m2): treatment group 1 (70.26 ± 19.2);
treatment group 2 (71.08 ± 15.8); treatment group 3 (70.19 ± 19.3)
◦ Mean baseline serum albumin (g/dL): not reported
◦ Mean baseline calorie intake (kcal): not reported
• Exclusion criteria: Pregnant or lactating women; SCr ≥ 176 mmol/L (≥ 2 mg/
dL); liver dysfunction (twofold or higher of the upper limit of normal in alanine
aminotransferase or aspartate aminotransferase); intestinal problems that would
prevent adherence to any of the test diets; active cancer
Interventions Treatment group 1
• Low fat diet
◦ Participants in this group were advised to consume die low in fat with
restricted calories
Treatment group 2
• Low carbohydrate diet
◦ Participants in this group were advises to consume diet low in carbohydrates
without calorie restriction
Treatment group 3
• Mediterranean diet
◦ Participants in this group were advised to consume diet based on
Mediterranean diet with calorie restrictions.
Co-interventions
• None
Outcomes • eGFR change
• Albumin to creatinine ratio
• Urine albumin
• Urine creatinine
Notes • Funding source: The Israeli Ministry of Health, Chief Scientist Office (Project
No. 300000-4850) and The Dr. Robert C. and Veronica Atkins Research Foundation.
• Additional data: none requested
• ClinicalTrials.gov number, NCT00160108
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit judge-
ment
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
29Dietary interventions for adults with chronic kidney disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
DIRECT Study 2013 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel not
reported in the study report. Participants
were randomised to either low fat, low car-
bohydrate, or Mediterranean diet. There-
fore, participants and investigators (dieti-
tians) were unlikely to be masked to treat-
ment allocation
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk The clinic and laboratory staff members
were unaware of the treatment assign-
ments, and the study coordinators were un-
aware of all outcome data until the end of
the intervention
Incomplete outcome data (attrition bias)
All outcomes
Low risk 322 participants were randomised, baseline
data were available for 318 participants.
Data for all randomised participants were
included in analyses in primary study re-
port
Selective reporting (reporting bias) High risk No pre-published study protocol. Unclear
whether treatment outcomes are reported
as planned. Data for mortality and ESKD
not reported
Other bias High risk Post-hoc reporting of subgroupswithCKD
Facchini 2003
Methods • Study design: parallel RCT
• Time frame: not reported
• Duration: 4 years
Participants • Country: USA
• Setting: single centre
• Inclusion criteria: adults with DKD; various degree of kidney failure, GFR 15 to
75 mL/min; unexplained proteinuria
• Number: treatment group (100); control group (91)
• Mean age ± SD (years): treatment group (59 ± 10); control group (60 ± 12)
• Sex (M/F): treatment group (53/47); control group (48/43)
• Baseline characteristics
◦ Mean baseline BMI (kg/m2): treatment group (28 ± 5); control group (28 ±
5)
◦ Mean baseline SCr (µmol/L): treatment group (159 ± 53); control group
(168 ± 62)
◦ Mean baseline GFR (mL/min): treatment group (64 ± 28); control group
(62±32)
◦ Mean baseline serum albumin (g/dL): not reported
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◦ Mean baseline calorie intake (kcal): not reported
• Exclusion criteria: kidney disease caused by other conditions than diabetes
Interventions Treatment group
• CR-LIPE diet
◦ 50% reduction of previous carbohydrate consumption, substitution of iron-
enriched red meats with iron poor white meats and with protein-enriched food items
known to inhibit iron absorption (diary, eggs and soy), elimination of all beverages
other than tea, water and red wine (milk was recommended for breakfast, tea was
highly recommended: red wine was not to exceed 150 mL with lunch and 150 mL
with dinner; outside mealtimes, water was the only approved beverage), lastly exclusive
use of polyphenol-enriched extra virgin olive oil for both dressing and frying was
recommended. Except for carbohydrate restriction, there was no other restriction on
protein and fat. Dietary adherence methods were not reported.
◦ Duration: mean follow-up 3.9 + 1.8 years
Control group
• Participants in control group were recommended diet standard protein restricted
diet (0.8 g/kg/d), isocaloric for ideal body weight maintenance, no specific
recommendations were given regarding pattern of beverage use (except for avoiding
sucrose-containing beverages). Dietary adherence methods were not reported.
• Duration: mean follow-up 3.9 + 1.8 years.
Co-interventions
• Not reported
Outcomes • Doubling of SCr
• ESKD: a sustained elevation of SCr concentration to levels > 530 µmol/L (6.0
mg%)), RRT, or transplantation
• All-cause mortality
Notes • Funding source: not reported
• Additional data: none requested
• Trial registration: not applicable as published before 2006
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit judge-
ment
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel not
reported in the study report. Participants
were randomised to either specific dietary
recommendation group or control group.
Therefore, participants and investigators
were unlikely to be masked to treatment al-
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location
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Masking of outcome assessment not re-
ported in the study report. Biochemical pa-
rameters are unlikely to be influenced by
knowledge of treatment group, however,
clinical outcomes such as mortality and
quality of life could have been affected by
knowledge of treatment allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk 9 participants in CR-LIPE group and 12
in control group loss to follow-up; with-
drawal reasons included loss of insurance
or moving out of town. Data available for
90% of population. No imbalance between
treatment groups
Selective reporting (reporting bias) Low risk No pre-published study protocol. Unclear
whether treatment outcomes are reported
as planned. Outcomes of mortality and
ESKD provided
Other bias Unclear risk Funding source not reported
Flesher 2011
Methods • Study design: parallel RCT
• Time frame: not reported
• Duration: 12 months
Participants • Country: Canada
• Setting: multicentre (nephrologist and general practitioner)
• Inclusion criteria: adults; GFR 20 to 60 mL/min for ≥ 3 months; presence of
urinary protein; hypertension or taking at least 1 anti-hypertensive medication;
physician approval to exercise
• Number: treatment group (26); control group (19)
• Mean age ± SD (years): treatment group (63.4 ± 12.1); control group (63.4 ± 11.
8)
• Sex (M/F): treatment group (14/9); control group (7/10)
• Baseline characteristics
◦ Mean body weight (kg): not reported
◦ Mean baseline SCr (units); not reported
◦ Baseline GFR (units); treatment group (37.2 ± 3.2); control group (38.4 ± 3)
◦ Mean baseline serum albumin (g/dL): not reported
◦ Mean baseline calorie intake (kcal): not reported
• Exclusion criteria: not reported
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Flesher 2011 (Continued)
Interventions Treatment group
• Standard nutritional counselling plus a group CKD nutrition class, CKD cooking
classes with a dietitian and cook educator, CKD cookbook and 12 week exercise
programme led by a certified exercise physiologist and nurse
◦ The classes were offered in English, Cantonese, and Mandarin to
accommodate the main languages spoken in the Richmond area. The cooking classes
were offered over 4 weeks for 2 hours a session, and an additional week included a
shopping tour led by a dietitian. Each cooking class focused on a different topic (self-
management, sodium, protein, potassium, phosphate, label reading/eating out), with
education provided by a dietitian and a cook educator leading participants in preparing
and tasting recipes from the provided CKD cookbook. The 12-week exercise class was
offered in the fully equipped gym consisted of 3 1-hour sessions per week with aerobic,
strength training, and flexibility components. Patients recorded their BP, monitored
their heart rates with a heart-rate monitor, and recorded both in an exercise log.
Control group
• Standard nutritional care including dietary counselling on moderate protein and
low sodium, with individualised modification of potassium and/or phosphate. Patients
did not complete food records, dietary history was discussed in detail at the individual
appointment. Intervention group
Co-interventions
• Not reported
Outcomes • eGFR reduction
• Total cholesterol reduction
• Urinary sodium reduction
• Urinary protein reduction
• BP reduction
Notes • Funding source: Vancouver Coastal Health Professional Research Award 2008
• Additional data: none requested
• Trial registration number: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit judge-
ment
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel not
reported in the study report. Participants
were randomised to standard nutritional
care or standard nutritional care plus group
nutrition class, cooking class and exercise
training. Therefore, the study was unlikely
to be blinded
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Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Masking of outcome assessment not re-
ported in the study report. Biochemical pa-
rameters are unlikely to be influenced by
knowledge of treatment group, however,
clinical outcome like improvement in BP
can be affected by knowledge of treatment
group
Incomplete outcome data (attrition bias)
All outcomes
Low risk 3/26 participants in intervention group did
not complete study (1 patient died in this
group of unrelated health issues); 2/19 par-
ticipants in control group did not complete
study. No imbalance between groups
Selective reporting (reporting bias) Low risk No pre-published study protocol. Unclear
whether treatment outcomes were reported
as planned. All-cause mortality data were
provided
Other bias Low risk Study appears free of other biases
Goraya 2013
Methods • Study design: parallel RCT
• Time frame: not reported
• Duration: 12 months
Participants • Country: USA
• Setting: single centre
• Inclusion criteria: adults; GFR of 15 to 29 mL/min/1.7 3m2; plasma TCO2 < 22
mM; no diabetes or cardiovascular disease; 2 or more primary care physician visits in
the preceding year
• Number: treatment group 1 (36); treatment group 2 (37)
• Mean age ± SD (years): treatment group 1 (53.9 ± 6.9); treatment group 2 (54.2 ±
5.3)
• Sex (M/F):treatment group 1 (20/16); treatment group 2 (18/17)
• Baseline characteristics
◦ Mean body weight (kg): treatment group 1 (82.7 ± 6.1); treatment group 2
(84.3 ± 5.4)
◦ Mean baseline SCr (mg/dL); treatment group 1 (3.9 ± 0.9); treatment group
2 (3.9 ± 0.3)
◦ Mean baseline GFR (units); not reported
◦ Mean baseline serum albumin (g/dL): not reported
◦ Mean baseline calorie intake (kcal): not reported
• Exclusion criteria: patients with primary kidney disease or findings consistent
with > 3 RBC/HPF or urine cellular casts; history of diabetes or fasting blood glucose
level > 110 mg/dL; current pregnancy; history of malignancies; chronic infections;
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clinical evidence of cardiovascular disease; peripheral oedema or diagnosis associated
with oedema, such as heart or liver failure or nephrotic syndrome; plasma potassium
level > 4.6 mEq/L; taking or inability to stop taking drugs that limit K+ excretion
Interventions Treatment group 1
Fruit and vegetable group
• Advised to consume fruit and vegetables. The patients in the fruits and vegetables
group received fruits and vegetables free of charge, prescribed by a dietitian and
distributed from the food bank in amounts to reduce potential renal acid load by half,
as done previously. Individuals were not given specific dietary instructions, and they
integrated the prescribed fruits and vegetables into their diets as they wished.
Treatment group 2
Sodium bicarbonate group
• Participants in this group were advised to take NaHCO3 tablets and no added
fruits and vegetables
All study individuals kept 3-day diaries before and after the intervention from which
potential renal acid load, ameasure of dietary acid intake, was calculated using a published
equation
Co-interventions
• Not reported
Outcomes • Weight
• BP
• Plasma creatinine
• Plasma cystatin C
• Potential renal acid load
• Plasma potassium
• Plasma sodium
• Plasma aldosterone
• Urinary fractional excretion of K+
• 8 h urine Na+ excretion
• Plasma TCO2
Notes • Funding source: The Larry and Jane Woirhaye Memorial Endowment in Renal
Research the Texas Tech University Health Sciences Centre, by the Statistics
Department of Scott and White Healthcare, and by the Academic Operations Division.
• Additional data: none requested
• Trial registration number not provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit judge-
ment
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel not
reported in the study report. Participants
were randomised to either sodium bicar-
bonate tablet or fruit and vegetables group.
Therefore, the study was unlikely to be
blinded
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Masking of outcome assessment not re-
ported in the study report. Biochemical pa-
rameters are unlikely to be influenced by
knowledge of treatment group
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Number of participants randomised was
provided, however, number of participants
completing study and those analysed not
provided
Selective reporting (reporting bias) High risk No pre-published study protocol. Unclear
whether treatment outcomes are reported
as planned.No key clinical outcomes (mor-
tality or ESKD) provided
Other bias Low risk Study appears free of other biases
Goraya 2014
Methods • Study design: parallel RCT
• Time frame: not reported
• Duration: 36 months
Participants • Country: USA
• Setting: single centre
• Inclusion criteria: adults; GFR 30 to 59 mL/min/1.73 m2; plasma TCO2 > 22
mM
• Number: treatment group 1 (36); treatment group 2 (36); control group (36);
• Mean age ± SD (years): treatment group 1(53.5 ± 5.2); treatment group 2 (53.6 ±
5.3); control group (53.9 ± 4.8);
• Sex (M/F): treatment group 1 (16/20); treatment group 2 (16/20); control group
(16/20);
• Baseline characteristics
◦ Mean body weight (kg): treatment group 1 (84.2 ± 6.1); treatment group 2
(84.1 ± 5.8); control group (83.1 ± 6);
◦ Mean baseline SCr (mg/dL): not reported
◦ Mean baseline GFR (units); not reported
◦ Mean baseline serum albumin (g/dL): not reported
◦ Mean baseline calorie intake (kcal): not reported
• Exclusion criteria: not reported
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Interventions Treatment group 1
• Fruit and vegetable group
◦ Advised to consume fruit and vegetables
Treatment group 2
• Sodium bicarbonate group
◦ Advised to take NaHCO3 tablets and no added fruits and vegetables
Control group
• Usual care
◦ Continued their usual treatment.
Co-interventions
• Not reported
Outcomes • Weight
• BP
• Potential renal acid load
• Plasma potassium
• Plasma sodium
• 8 h urine Na+ excretion
• Plasma TCO2
• Venous pH
• GFR
Notes • Funding source: The Larry and Jane Woirhaye Memorial Endowment in Renal
Research the Texas Tech University Health Sciences Centre, by the Statistics
Department of Scott and White Healthcare, and by the Academic Operations Division
• Additional data: none requested
• Trial registration number not provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit judge-
ment
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel not
reported in the study report. Participants
were randomised to either sodium bicar-
bonate tablet or fruit and vegetables or
usual care group. Therefore, the study was
unlikely to be blinded
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Masking of outcome assessment not re-
ported in the study report. Biochemical pa-
rameters are unlikely to be influenced by
knowledge of treatment group
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Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Number of participants randomised is pro-
vided, however, number of participants
completing study and those analysed not
provided
Selective reporting (reporting bias) High risk No pre-published study protocol. Unclear
whether treatment outcomes are reported
as planned.No key clinical outcomes (mor-
tality or ESKD) provided
Other bias Low risk Study appears free of other biases
Leon 2006
Methods • Study design: cluster RCT
• Time frame: February 2002 to September 2003
• Duration: 12 months
Participants • Country: USA
• Setting: multicentre (47 long-term HD facilities)
• Inclusion criteria: Adults age 18 to 85 years; serum albumin level and mean serum
albumin level for previous 3 months both < 3.70 g/dL (bromcresol green method) or <
3.40 g/dL (bromcresol purple method); treated with dialysis for at least 9 months
• Number: treatment group (86); control group (94)
• Mean age (years): treatment group (62); control group (60)
• Sex (M/F): treatment group (36/50); control group (44/50)
• Baseline characteristics
◦ Mean body weight (kg): treatment group (81.3); control group (78.0)
◦ Mean BMI (kg/m2): treatment group (29.0); control group (27.9)
◦ Mean baseline SCr (mg/dL): not reported
◦ Mean baseline GFR (units); not reported
◦ Mean baseline serum albumin (g/dL): treatment group (3.4); control group
(3.4)
◦ Mean time on dialysis (years): treatment group (2.8); control group (3.1)
◦ Mean baseline energy intake (Kcal/d/kg): treatment group (0.83); control
group (0.8)
• Exclusion criteria: people who did not speak English; mental impairment; unique
nutritional issues (i.e., nursing home residents; people with cirrhosis; acquired
immunodeficiency syndrome; active malignancy; terminal illness; tube feeding; and
total parenteral nutrition).
Interventions Treatment group
• Study coordinators educated people in this group about the meaning and
importance of good nutritional status. They then provided feedback and
recommendations. The information was provided during a dialysis treatment and was
tailored to the specific barriers present. Study coordinators also communicated
information about barriers to facility dietitians and modified recommendations.
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Participants received education about high protein foods using interactive activities,
self-teaching activities and handouts. Study coordinators recommended increasing
specific foods for which patients had preserved appetite and provided limited amounts
of supplements such as nutrition drinks and cookies. Study coordinators in
collaboration with facility dietitians and social workers explored the possibility of
obtaining help from family, friends, and social support agencies. Participants were
recommended to add a protein-containing beverage to diet. In addition, the following
were addressed: dialysis dose, depression, difficulty chewing, difficulty swallowing,
gastrointestinal symptoms, and acidosis
Control group
• Usual care from nephrologists, dietitians, and social workers. Study coordinators
met monthly and administered questionnaires related to dietary intake, nutritional
barriers, and quality of life
Co-interventions
• Not reported
Outcomes • Change in serum albumin level
• Weight
• Dietary intake
• Subjective global assessment
• Overcoming nutritional barriers
• Quality of life
Notes • Funding source: grants DK51472 and GCRC M01 RR00080 from the National
Institutes of Health; Leonard C Rosenberg Renal Research Foundation
• Additional data: none requested
• Trial registration number not provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated sequence
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Insufficient information to permit judge-
ment; unlikely to be adequately masked
due to nature of intervention
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Insufficient information to permit judge-
ment
Incomplete outcome data (attrition bias)
All outcomes
High risk 17/103 people in intervention group and
11/105 people in control group not in-
cluded in analyses
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Selective reporting (reporting bias) High risk No pre-published study protocol. Unclear
whether treatment outcomes are reported
as planned.No key clinical outcomes (mor-
tality or ESKD) provided
Other bias High risk Did not account for effect of clustering in
statistical analysis
Mekki 2010
Methods • Study design: parallel RCT
• Time frame: January to April 2008
• Duration: 3 months
Participants • Country: Algeria
• Setting: single centre
• Inclusion criteria: adults; moderate non dialysed CKD; GFR 60 to 89 mL/min;
dyslipidaemia (triglycerides > 1.7 mmol/L and/or total cholesterol > 5 mmol/L)
• Number: treatment group (20); control group (20)
• Mean age ± SD (years): treatment group (59 ± 12); control group (60 ± 10)
• Sex (M/F): treatment group (10/10); control group (10/10)
• Baseline characteristics
◦ Mean body weight (kg): treatment group (73 ± 11); control group (76 ± 14)
◦ Mean baseline SCr (µmol/mL): treatment group (151 ± 57); control group
(189 ± 70)
◦ Mean baseline GFR (units): treatment group (70 ± 10); control group (75 ±
15)
◦ Mean baseline serum albumin (g/L): treatment group (3.8 ± 0.6); control
group (3.2 ± 0.5)
◦ Mean baseline calorie intake (kcal): not reported
• Exclusion criteria: DKD; thyroid disease; use of anti-inflammatory drugs,
antioxidants or vitamins
Interventions • All patients received nutritional advice based on the NKF K/DOQI (National
Kidney Foundation-Kidney Disease Outcomes Quality Initiative) guidelines (energy
intake of 0.12 MJ/kg BW/d, protein intake 0.75 g/kg BW/d, lipid intake 35% and
carbohydrates 55% of total energy intake)
• The food consumption survey used the method of “recall and record”, repeated
every 4 days. Patients were interviewed by trained interviewers using an adapted and
structured questionnaire
Treatment group
• Dietary recommendations in this group were modified and adapted to a
Mediterranean diet, with increased intake of MUFA, PUFA and fibres. Participants
consumed olive oil and nuts for seasonings, whole grains (50 g of bread at each meal,
250 g of cereal or starch once a day), fruits (once a day), vegetables (200 g twice daily)
and fish (twice a week). A list of foods rich in salt, potassium and phosphorus was
provided. In addition, patients received advice about the cooking methods best suited
for adherence to a Mediterranean diet
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Control group
• No modification to the NKF K/DOQI guidelines were made in this group
Co-interventions
• None specified
Outcomes • Food intake composition
• Qualitative food intake
• SCr
• GFR
• Serum urea
• Serum urate
• Serum iron
• Serum bilirubin
• Hb
• Serum albumin
• CRP
• Fibrinogen
• Serum cholesterol, HDL cholesterol, LDL cholesterol
• Triglycerides
Notes • Funding source: this work was supported by the National Agency of Health
Research
• Additional data: none requested
• Trial registration number not provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit judge-
ment
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel not
reported in the study report. Participants
were randomised to either modified diet
Mediterranean diet group or control group.
Therefore, the study was unlikely to be
blinded
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Masking of outcome assessment not re-
ported in the study report. Biochemical pa-
rameters are unlikely to be influenced by
knowledge of treatment group
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Only number of participants randomised
provided
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Selective reporting (reporting bias) High risk No pre-published study protocol. Unclear
whether treatment outcomes are reported
as planned.No key clinical outcomes (mor-
tality or ESKD) provided
Other bias Low risk Study appears free of other biases
Orazio 2011
Methods • Study design: parallel RCT
• Time frame: not reported
• Duration: 24 months
Participants • Country: Australia
• Setting: Single centre
• Inclusion criteria: ≥ 6 months after kidney transplantation; stable transplant;
regular follow-up
• Number: treatment group (56); control group (46)
• Mean age ± SD (years): treatment group (54.9 ± 9.9) control group (54.7 ± 11.8)
• Sex (M/F): treatment group (33/23); control group (29/17)
• Baseline characteristics
◦ Mean body weight (kg): treatment group (83 ± 20); control group (83 ± 18)
◦ Mean BMI (kg/m2): treatment group (29 ± 5); control group (29 ± 6)
◦ Median time after kidney transplantation, range (years): treatment group (6.
05, 0.60 to 31.90); control group (4.55, 0.50 to 26.10)
◦ Mean baseline SCr (µmol/mL): not reported
◦ Mean baseline GFR (units): treatment group (54 ± 20); control group (48 ±
17)
◦ Mean baseline serum albumin (g/L): not reported
◦ Mean baseline energy intake, range (kJ): treatment group (8334, 5502 to 12,
031); control group (8539, 6646 to 12,418)
• Exclusion criteria: Not reported in study publication.
Interventions Treatment group
• Individualised dietary advice including achievement and/or maintenance of a
healthy weight (BMI 20 to 25 kg/m2) using a Mediterranean style diet (< 30% total
energy from fat), low GI diet. A moderate energy deficit of 500 kcal/d (2000 kJ/d) was
used to promote 0.5 kg weight loss/week. Study materials included a study manual
with dietary and lifestyle information, food models and pictures. The long-term goal of
physical activity advice was to achieve 150 minutes of accumulated physical activity per
week. Goals were individualised according to mobility, fitness, personal preference, and
self-efficacy for activities. Moderate physical activity such as walking was encouraged,
both as a structured activity and activity of daily living. The Transtheoretical Model of
Health Behaviour Change or Stage of Change Model underpinned the lifestyle
intervention and was used to provide a framework for goal-setting in the study. The
intervention was delivered by multidisciplinary team including dietitian, nephrologist,
nurse and endocrinologist
Control
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• Standard care
Co-interventions
• Not reported
Outcomes • Anthropometric: weight, BMI, waist circumference, waist-to-hip ratio
• HbA1c
• Total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides
• Dietary intake: energy, protein, fat (total, poly, mono, saturated), carbohydrates,
fibre
• Physical activity
• VO2 max
Notes • Funding source: Allied Health Research Scheme from Queensland Health; Allied
Health Research Scholarship from the Princess Alexandra Hospital Foundation.
• Additional data: none requested
• Trial registration number not provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit judge-
ment
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Insufficient information to permit judge-
ment; unlikely due to the nature of the in-
terventions
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Insufficient information to permit judge-
ment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Number of participants who were ran-
domised and completed follow up not re-
ported. Unclear whether completeness of
follow up similar for each treatment group
Selective reporting (reporting bias) High risk No pre-published study protocol. Unclear
whether treatment outcomes are reported
as planned.No key clinical outcomes (mor-
tality or ESKD) provided
Other bias Low risk Study appears free of other biases
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Methods • Study design: parallel RCT
• Time frame: not reported
• Duration: 6 months
Participants • Country: Italy
• Setting: not reported
• Inclusion criteria: adults with CKD stage 3B- 5
• Number: Treatment group 1 (27); treatment group 2 (27)
• Mean age (years): treatment group 1 (66.6); treatment group 2 (61.5)
• Sex (M/F): not reported
• Baseline characteristics
◦ Mean body weight (kg): not reported
◦ Mean baseline SCr (units): not reported
◦ Baseline GFR (units): not reported
◦ Mean baseline serum albumin (g/dL): not reported
• Exclusion criteria: not reported.
Interventions Treatment group 1
• 6-point diet
◦ Advice on dietary modification, instructions were provided by a
nephrologist. Instructions focused on 6 points, including salt restriction, replacing
food items, foods allowed and its quantity including animal products and fruit and
vegetable and combining different food items. Adherence to diet was assessed at regular
intervals (1, 3 and 6 months), method for assessing adherence was not reported.
• Duration: 6 months
Treatment group 2
• Low protein diet
◦ Instructed to consume diet containing 0.7 to 0.8g/kg/d protein diet.
Adherence to diet was assessed at regular intervals (1, 3 and 6 months), method for
assessing adherence was not reported
• Duration: 6 months
Co-interventions
• Not reported
Outcomes • Protein intake
• Phosphate intake
• Weight loss
• GFR (data not extractable)
Notes • Funding source: not reported
• Additional data: none requested
• Abstract-only publication
• Trial registration number not provided
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit judge-
ment
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel not
reported in the study report. Participants
were randomised to either 6 point dietary
modification group of low protein dietary
modification group. Therefore, the study
was unlikely to be blinded
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Insufficient information to permit judge-
ment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Number of participants randomised re-
ported, number of participants who com-
pleted or withdrew not provided
Selective reporting (reporting bias) High risk No pre-published study protocol. Unclear
whether treatment outcomes are reported
as planned. Clinical outcomes (mortality,
ESKD) not provided
Other bias High risk Insufficient reporting information to adju-
dicate risk; published only as conference
proceeding; funding source(s) not disclosed
Stachowska 2005
Methods • Study design: parallel RCT
• Time frame: not reported
• Duration: 6 months
Participants • Country: Poland
• Setting: single centre
• Inclusion criteria: kidney transplant recipients; stable graft function; non-smoker
• Number: treatment group (21); control group (16)
• Mean age ± SD (years): treatment group (41 ± 12.5); control group (46 ± 9.5)
• Sex (M/F): not reported
• Baseline characteristics
◦ Mean time with kidney transplant, range (months): treatment group (10.7,
2 to 24); control group (11.3, 1 to 31)
◦ Mean BMI (kg/m2): treatment group (25.0 ± 4.1); control group (26.2 ± 4.
4)
◦ Mean baseline SCr level (mg/dL): treatment group (1.62 ± 0.57); control
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group (1.73 ± 0.054)
◦ Mean baseline GFR (mL/min/1.73 m2): not reported
◦ Mean baseline serum albumin (g/dL): not reported
◦ Mean baseline calorie intake (kcal): not reported
• Exclusion criteria: not reported
Interventions Treatment group
• Mediterranean diet in the form of 4-week all-day menus
◦ Daily energy intake was attributed as follows: 47% carbohydrates, 38% fatty
acids (including 10% saturated, 22% monounsaturated and 6% polyunsaturated
species) and 15% protein. Cholesterol and fibre supply was 165 ± 17 mg/d and 47 ± 9
g/d respectively. The dominating fatty acid was oleic acid from olive oil and erucic
acid-poor rapeseed oil. Patients consumed 30 mL cold-pressed olive oil per day (fresh
salads) and prepared their cooked meals exclusively with rapeseed oil. Patients
consumed approximately 30 g daily of products rich in a-tocopherol and a-linolenic
acid C18:3n-3 (grains, flax-seed, nuts). The carbohydrate component contained less
glucose (low glycaemic index). Allowable products included cereals, pulses, wholemeal
bread, vegetables (fresh and cooked), oat flakes (cooked) and spaghetti. The patients
were advised to consume fresh vegetables with every meal. The daily animal protein
consumption was 25 to 50 g for men and 23 to 46 g for women, representing one-
third of the total protein. No additional vitamin supplementation was offered.
Control group
• Standard care (low-fat diet isocaloric with the study diet)
◦ Patients were asked to take home and complete a 24 h diet diary. The diet
diary booklet contained menus, pages to record foods, and photographs of food that
depicted portion choices for a common food item. The dietician indicated that the
patient should record the food brand and portion size. The amounts consumed were
recorded in household units, by volume or by measuring with a ruler. Each person was
interviewed about their dietary pattern in the previous month. Daily energy intake was
attributed as follows: 57% carbohydrates, 26% fatty acids and 17% protein.
Cholesterol and fibre supply was 257 (SD 15) mg/d and 24 (SD 13) g/d respectively.
The carbohydrate component was poor in cellulose and rich in starch (white bread,
potatoes, rice). The fat content was lower than in the study group, with
polyunsaturated (mainly C18:2n-6) fats dominating. Questionnaires revealed that
butter and sunflower oil were the main source of fat in this group. Daily animal protein
consumption was higher than in the study group (approximately 70 g for men and 50
g for women), whereas the consumption of fruit and fresh vegetables was lower. The
diet was not supplemented with vitamins.
Co-interventions
• None
Outcomes • Plasma lipids
• Thiobarbituric acid-reactive substances in plasma and erythrocytes
• CRP
• Plasma a-tocopherol
• Superoxide dismutase
• Catalase
• Glutathione peroxidase
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Notes • Funding source: Research grant No. 130-649 from the Pomeranian Medical
University, Szczecin, Poland
• Additional data: none requested
• ClinicalTrials.gov number: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit judge-
ment
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel not
reported in the study report. Masking was
unlikely due to the nature of the interven-
tions
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Insufficient information to permit judge-
ment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information to permit judge-
ment
Selective reporting (reporting bias) High risk No pre-published study protocol. Unclear
whether treatment outcomes are reported
as planned. Data for mortality and ESKD
not reported
Other bias High risk Typographical errors precluded assessment
of baseline characteristics
Sutton 2007
Methods • Study design: parallel RCT
• Time frame: not reported
• Duration: 4 months
Participants • Country: UK
• Setting: single centre
• Inclusion criteria: People treated with CAPD (without diabetes) for a minimum
of 3 months
• Number: treatment group (30); control group (29)
• Mean age ± SD (years): treatment group (60.7 ± 15.5); control group (58.5 ± 15.
4)
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• Sex (M/F): treatment group (15/11); control group (12/11)
• Baseline characteristics
◦ Mean body weight (kg): treatment group (72.8 ± 12.9); control group (72.0
± 12.1)
◦ Mean baseline BMI (kg/m2): treatment group (25.4 ± 3.8); control group
(25.7 ± 3.4)
◦ Mean baseline SCr (µmol/mL): not reported
◦ Mean baseline GFR (mL/min): not reported
◦ Mean time on dialysis: not reported
◦ Mean baseline serum albumin (g/L): treatment group (3.71 ± 0.3); control
group (3.72 ± 0.32)
◦ Mean baseline calorie intake (cal/kg): treatment group (23.4 ± 6.1); control
group (25.7 ± 5.9)
• Exclusion criteria: known malabsorption; celiac disease; malignancy; dementia;
pregnancy; CKD; eating disorders
Interventions Treatment group
• Offered follow-up dietary advice that would encourage them to match energy
intake with their estimated energy expenditure allowing for dialysate calories and with
a protein intake of not less than 0.8 to 1.0 g/kg IBW. The allowance for dialysate
calories was 5 cal/kg based on the median of results of analysis of 24-hour dialysate
effluent. Suggestions of how to achieve a match were given as snack ideas, alterations in
food preparation, or modification of portion sizes, individualized in each case to suit
the preferences and eating patterns of the person participating. The reports were posted
to the participants to overcome variations in clinic attendance and accessibility to the
renal unit on the basis of geographic distance. Actual face-to-face contact with the
research dietitian took place at baseline and 4 months.
Control group
• Standard care
Co-interventions
• None specified
Patients were encouraged to contact the research dietitian if they needed further dietary
advice
Outcomes • Death
• Transfer to HD
• Protein and energy intakes
• Potassium intake
• Phosphorus intake
• Serum albumin
• Potassium
• Phosphate
• Body weight
• Mid-arm circumference
Notes • Funding source: not reported
• Additional data: none requested
• Trial registration number not provided
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel not
reported in the study report. Masking was
unlikely due to the nature of the interven-
tions. “Although the patient information
described the purpose of the study, patients
were not explicitly told which group they
were in.”
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Insufficient information to permit judge-
ment
Incomplete outcome data (attrition bias)
All outcomes
High risk 4/30 excluded from analysis in treatment
group; 6/29 excluded from analysis in con-
trol group
Selective reporting (reporting bias) High risk No pre-published study protocol. Unclear
whether treatment outcomes are reported
as planned
Other bias Unclear risk Funding source not reported
Teng 2013
Methods • Study design: parallel RCT
• Time frame: November 2008 to October 2009
• Duration: 24 months
Participants • Country: Taiwan
• Setting: Single centre
• Inclusion criteria: adults; early CKD with a normal to moderately reduced GFR;
able to communicate in Mandarin or Taiwanese
• Number: treatment group (80); control group (80)
• Mean age ± SD (years): treatment group (62.1 ± 14); control group (65.65 ± 11.2)
• Sex (M/F): treatment group (33/19); control group (40/11)
• Baseline characteristics
◦ Mean body weight (kg): not reported
◦ Mean baseline SCr (µmol/mL): not reported
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◦ Mean baseline GFR (mL/min): treatment group (53.74 ± 18.28); control
group (49.54 ± 13.29)
◦ Mean baseline serum albumin (g/L): not reported
◦ Mean baseline calorie intake (kcal): not reported
• Exclusion criteria: co-morbid conditions like heart, lung, neurological, or skeletal
muscular diseases that prohibited exercise; psychiatric problems; needed assistance in
the basic activities of daily living
Interventions Treatment group
• Provided with five targeted interventions were to promote or maintain positive
dietary behaviours, and five targeted interventions to promote or maintain positive
exercise behaviours. Participants assigned to the treatment group were provided a face-
to face counselling and information by the research assistants according to their self-
reported stage of change at each visit related to diet and exercise lifestyle behaviours:
pre-contemplation, contemplation, preparation, action, or maintenance.
• The Lifestyle Modification Program, aimed at enhancing a patient’s motivation-
to-change behaviour, provided an opportunity to discuss the reasons why he or she was
not able to achieve the set goals and implement lifestyle modification interventions.
The goal of the program was to promote the participant’s intention with regard to
lifestyle modification for slowing kidney disease progression. The targeted treatment
group was determined at each clinic visit after the participants had completed the
TTM staging inventory for dietary and lifestyle behaviours. The interventions were
delivered by registered nurse research assistants who had received 8 hr of theoretical
and practical training in the Lifestyle Modification Program and attended weekly
debriefing meetings with the research investigators.
Control group
• Received face-to-face standard education by the trained research assistants on
healthy eating for proper protein, low-salt, and low-fat diet, and on benefits of regular
exercise at least 3 times a week for 20 min per session
Co-interventions
• Not reported
Participants in both groups received a follow-up telephone call to remind them of their
appointment 1 month prior to each return clinic visit
Outcomes • Change in stages of dietary and exercise behaviour
• Health promoting lifestyle profile-II
Notes • Funding source: funded by National Science Council, Taiwan NSC95-2314-B-
006-082-MY3.
• Additional data: none requested
• Trial registration number not provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit judge-
ment
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Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel not
reported in the study report. Participants
were randomised to either lifestyle modifi-
cation group or standard care. Therefore,
the study was unlikely to be blinded
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Insufficient information to permit judge-
ment. Parameters measured in this study
were likely to be influenced by knowledge
of treatment allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk 63% of participants in control group and
59% of participants in treatment group
completed 12 months of study. No imbal-
ance between groups
Selective reporting (reporting bias) High risk No pre-published study protocol. Unclear
whether treatment outcomes are reported
as planned. Clinical outcomes (mortality,
ESKD) not provided
Other bias Low risk Study appears free of other biases
Tzvetanov 2014
Methods • Study design: parallel RCT
• Time frame: not reported
• Duration: 12 months
Participants • Country: USA
• Setting: single centre
• Inclusion criteria: kidney transplant recipients; obesity (not defined)
• Number: treatment group (9); control group (8)
• Mean age ± SD (years): treatment group (46 ± 6.9); control group (45 ± 19)
• Sex (M/F): treatment group (5/5); control group (3/5)
• Baseline characteristics
◦ Mean body weight (kg): not reported
◦ Mean BMI (kg/m2): treatment group (38.6 ± 4.89); control group (39.24 ±
6.42)
◦ Mean SCr (mg/dL): treatment group (1.68 ± 0.64); control group (1.52 ± 0.
42)
◦ Mean baseline GFR (mL/min): treatment group (47.5); control group (52)
◦ Mean baseline serum albumin (g/L): not reported
◦ Mean baseline calorie intake (kcal): not reported
• Exclusion criteria: ambulatory or significant orthopaedic problems, cardiac or
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pulmonary disease that contraindicated the physical training, contraindications to
exercise testing according to American Heart Association criteria, and inability to
comply with the rehabilitation program
Interventions Treatment group
• Personalised approach for physical rehabilitation (GH method). The ”GH’
method consisted of individual physical training (one-to-one resistance-based weight
training with two 1-hour sessions each week in a private environment. The objective of
the exercise protocol was to maximise adherence, improve medical health, reduce pain,
improve energy, and enhance emotional wellness and quality of life. Each session had a
clearly defined protocol incorporating physical, educational, and psychological aspects.
The protocol leveraged 3 main strategies: resistance training; changing thinking and
feeling patterns; coaching to make sustainable changes to lifestyle
Control group
• Standard of care for kidney transplant recipients, which included dietary and
exercise counselling by the transplant nutritionist at the time of transplantation and
additional dietary and exercise counselling by the transplant physicians at post-
transplantation clinic visits
Outcomes • BMI
• Total body mass
• Body fat percentage
• BP
• Pulse wave velocity
• Intimal-medial thickness
• eGFR
• SCr
• Lipids
• HbA1c
• SF-36 score
• Subjective pain assessment
• Employment
Notes • Funding source: not reported
• Additional data: none requested
• Trial registration number not provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit judge-
ment
Allocation concealment (selection bias) Unclear risk Prepared sealed envelopes containing a
card indicated the allocated treatment
group. Not reported whether envelopes
were opaque or sequentially numbered
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel not
reported in the study report. Participants
were randomised to either lifestyle modifi-
cation group or standard care. Therefore,
the study was unlikely to be blinded
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Insufficient information to permit judge-
ment. Parameters measured in this study
were likely to be influenced by knowledge
of treatment allocation
Incomplete outcome data (attrition bias)
All outcomes
High risk Only 4 people allocated to the control
group attended follow up at 6 months and
2 at 12 months
Selective reporting (reporting bias) High risk No pre-published study protocol. Unclear
whether treatment outcomes are reported
as planned
Other bias Unclear risk Funding source not reported
Whittier 1985
Methods • Study design: parallel RCT
• Time frame: not reported
• Duration: 1 month (28 days)
Participants • Country: USA
• Setting: single centre
• Inclusion criteria: kidney transplant recipients
• Number: treatment group (6); control group (6)
• Mean age ± SD (years): not reported
• Sex (M/F): treatment group (4/2); control group (5/1)
• Baseline characteristics
◦ Mean body weight (kg): treatment group (71 ± 5); control group (68 ± 5)
◦ Mean BMI (kg/m2): not reported
◦ Mean SCr (mg/dL): not reported
◦ Mean baseline GFR (mL/min): not reported
◦ Mean baseline calorie intake (calories/d): treatment group (1941 ± 122);
control group (2097 ± 291)
• Exclusion criteria: > 55 years; diabetes
Interventions Treatment group
• A general daily diet order was prescribed for all patients; it consisted of 800 mL
fluid restriction plus an amount equal to the urine volume/d, 2 g sodium, 80 mEq
potassium, 800 to 1200 mg of calcium, and 30 calories/kg. However, the composition
of the diet was determined according to inclusion into either the experimental or
control group. Total calories and content of the diet, in identical proportions, were
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adjusted up or down per kilogram to the nearest 10 kg for patients who weighed more
or less than 70 kg since the ideal body weight of these patients varied from 50 to 90 kg
prior to transplantation. The experimental diet (for a 70 kg person) included 210
grams protein (higher than the control diet), 70 grams carbohydrate (lower than
control) and the same amount of fat as the control diet
Control group
• A general daily diet order was prescribed for all patients; it consisted of 800 mL
fluid restriction plus an amount equal to the urine volume/d, 2 g sodium, 80 mEq
potassium, 800 to 1200 mg of calcium, and 30 calories/kg. However, the composition
of the diet was determined according to inclusion into either the experimental or
control group. Total calories and content of the diet, in identical proportions, were
adjusted up or down per kg to the nearest 10 kg for patients who weighed more or less
than 70 kg since the ideal body weight of these patients varied from 50 to 90 kg prior
to transplantation. The experimental diet included 70 grams protein (lower than
experimental diet), 210 grams carbohydrate (higher than experimental) and the same
amount of fat as the experimental diet.
Co-interventions
• Standard immunosuppression and pulse steroids for acute rejection
Outcomes • Nitrogen and electrolyte balance
• Energy intake
• Protein intake
• Sodium and potassium balance
• Muscle mass
• Glucose tolerance
• HbA1c
• Acute rejection
• BUN
• Serum potassium
Notes • Funding source: General Clinical Research Center of the University of Missouri-
Columbia Medical Center, Grant No, RR00287
• Additional data: none requested
• Trial registration number not applicable
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit judge-
ment
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel
not reported in the study report. Partici-
pants were randomised to either in-patient
study group or standard care. Therefore,
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the study was unlikely to be blinded
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Insufficient information to permit judge-
ment. Parameters measured in this study
were unlikely to be influenced by knowl-
edge of treatment allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk The proportion of people who were ran-
domised and included in final analysis not
reported
Selective reporting (reporting bias) High risk No pre-published study protocol. Unclear
whether treatment outcomes are reported
as planned
Other bias Low risk Study appears free of other biases
Zhou 2011b
Methods • Study design: parallel RCT
• Time frame: April 2009 to April 2010
• Duration: 6 months
Participants • Country: China
• Setting: single centre
• Inclusion criteria: adults 18 to 70 years and receiving PD > 3 months
• Number: treatment group (52); control group (50)
• Mean age ± SD (years): treatment group (57.8 ± 12.8); control group (59.9 ± 13.
6)
• Sex (M/F): treatment group (38/14); control group (34/16)
• Baseline characteristics
◦ Mean body weight (kg): not reported
◦ Mean BMI (kg/m2): treatment group (23.3 ± 4.5); control group (22.8 ± 6.
2)
◦ Mean SCr (mg/dL): not reported
◦ Mean baseline GFR (mL/min): not reported
◦ Mean baseline calorie intake: not reported
• Exclusion criteria: aged < 18 or > 70 years; ready to receive transplantation within
6 months; unable to eat by mouth or receive enteral nutrition; severe infection;
malignancy; non-kidney organ dysfunction
Interventions Treatment group
• According to the individualized nutrition treatment group regimen developed by
dietitians with regard to patients’ general condition, nutritional status and
characteristics, patients from the study group received treatment group as below: the
amount of energy was 125 kJ/(kg·d), the amount of proteins was 1.2-1.3 g/(kg·d), and
the proportion of proteins of high biological value was 70% to 75%. Oral enteral
nutritional supplements were used for those who did not get enough nutrients from
55Dietary interventions for adults with chronic kidney disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Zhou 2011b (Continued)
food. The volume of water intake was urinary volume at last day plus 500 mL, and the
amount of sodium was 3 g/d. The investigators were informed of the detailed status of
nutrient intake weekly in a face-to-face manner. Participants also received psychological
support and nurse-led exercise training
Control group
• Routine care
Co-interventions
• None reported
Outcomes • Nutritional status: malnutrition
• Anthropomorphic data: triceps skin-fold thickness; upper arm circumference; arm
muscle circumference; grip strength
• Quality of life: KDTA; SF-36
Notes • Funding source: not reported
• Additional data: none requested
• Trial registration number: not reported
• Journal article was professionally translated from Chinese to English before data
extraction
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation table
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Masking of patients or study personnel
not reported in the study report. Partici-
pants were randomised to either in-patient
study group or standard care. Therefore,
the study was unlikely to be blinded
Blinding of outcome assessment (detection
bias)
Objective outcomes
High risk Insufficient information to permit judge-
ment. Parameters measured in this study
were likely to be influenced by knowledge
of treatment allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2/52 participants in the control group
withdrew
Selective reporting (reporting bias) High risk No pre-published study protocol. Unclear
whether treatment outcomes are reported
as planned
Other bias Unclear risk Funding source(s) not reported
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BMI - body mass index; BP - blood pressure; BUN - blood urea nitrogen; CKD - chronic kidney disease; CR-LIPE - carbohydrate-
restricted, low-iron, polyphenol enriched; CRP - C-reactive protein; DKD - diabetic kidney disease; DBP - diastolic blood pressure;
ESKD - end-stage kidney disease; (e)GFR - (estimated) glomerular filtration rate; Hb - haemoglobin; HbA1c - glycolated Hb; HD
- haemodialysis; HDL - high density lipoprotein; HPF - high power field; KDTA - ; LDL - low density lipoprotein; M/F - male/
female; PD - peritoneal dialysis; RBC - red blood cells; RCT - randomised controlled trial; SBP - systolic blood pressure; SCr -
serum creatinine; SD - standard deviation; TCO2 - total carbon dioxide
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Parillo 1988 Short duration (2 isoenergetic diets, composed exclusively of natural foods, were given to patients in a random order
for periods of 10 consecutive days)
Characteristics of ongoing studies [ordered by study ID]
INTENT Study 2014
Trial name or title The INTENT trial: The effect of intensive nutrition interventions on weight gain after kidney transplantation
- a randomised controlled trial
Methods • RCT
Participants • Adult kidney transplant recipients, aged > 18 years, who reside and undergo transplant surgery in the
Auckland region
• Willing to participate in all study procedures for duration of follow-up
• Written informed consent
• Stable graft function (as determined by the treating Nephrologist)
Interventions Treatment group
• Intensive programme over 12 months of nutrition assessment, education and advice from a specialist
renal dietitian, commencing in the first month after kidney transplantation. This is in addition to standard
post kidney transplant care (see control treatment description). Patients allocated to the intensive nutrition
group will see a dietitian fortnightly for the first 3 months post-transplant, monthly from 4 to 6 months,
and bi-monthly until 12 months (i.e. a total of 12 visits). These visits will last between 30 min and 1 hour
on each occasion. Nutrition assessment and education will include regular reviews of dietary intake and
weight/anthropometry, and advice focusing on:
◦ Energy/caloric intake at an appropriate level to achieve a healthy weight and/or weight loss if
overweight or obese
◦ Protein intake to prevent loss of lean muscle mass, i.e. 1.3 to 1.5 g/kg/d in the early period,
followed by recommended daily intake of protein for the general population of body weight for males/
females for long term stable period
◦ Fat intake to ensure total energy from fat < 30% to 35%; with saturated fat and trans fatty acids <
8%
◦ Carbohydrate intake to ensure adequate fibre intake, low glycaemic index foods
◦ Dietary calcium and ensure vitamin D supplementation use if required
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INTENT Study 2014 (Continued)
◦ Food safety to ensure dietary requirements are met while food safety precautions are followed
◦ Tailored advice regarding physical activity and exercise, including consultation with an exercise
physiologist (approximately 30 minutes at 8 weeks, 12 months and 6 months post-transplant)
• Adherence to the intervention among participants randomised to this group will be determined using
the following measures:
◦ 3-Day food diary: to assess change in dietary habits and adherence to change
◦ Motivational assessment rulers: to assess motivation to change and elicit change (Miller/Rollnick
tools)
◦ Patient centred goals: assess if achieved individualised goals
◦ Review patient action plans: review of action steps taken
◦ Patient self-goal rating scale based on goal attainment scaling (GAS)
Control group
• Standard care post kidney transplant, including all routine medical and surgical care, including
immunosuppression, monitoring and prophylaxis of infection.
Outcomes Primary outcome
• Change in weight (kg) between baseline and 6 months after kidney transplant
Secondary outcomes
• Change in weight and anthropometry measures post-transplant
◦ Weight (kg)
◦ BMI (kg/m2)
◦ Waist-hip circumference ratio
◦ Seated blood pressure
◦ Mid arm circumference
◦ Skin fold thickness
• Change in body composition parameters post-transplant:
◦ Deuterium measurement analysis to determine total body water
◦ Dual energy X-ray absorptiometry (DEXA) to determine bone mass and fat mass
◦ In vivo neutron activation analysis to determine total body protein
◦ Total body potassium analysis to assess body cell mass
◦ Bioelectrical impedance as surrogate measure of total body water, extracellular water, fat mass and
lean body mass
• Change in biochemical measures post-transplant:
◦ SCr, full blood count, electrolytes, calcium, phosphate and liver enzymes (non-blinded)
◦ Immunosuppression drug levels (non-blinded)
◦ Fasting glucose
◦ Fasting insulin and determination of homeostatic model assessment index of insulin resistance
(HOMA)
◦ HbA1c
◦ Serum cholesterol and triglycerides
• Level of physical activity and physical functional capacity post-transplant:
◦ Physical activity questionnaire
◦ Six metre gait assessment (maximum walking speed over a 6 metre distance)
◦ Hand grip strength (dynamometry)
◦ Sit to stand to sit test (lower extremity strength)
• Quality of life as measured using the (short-form 36 (SF-36) questionnaire
• Adherence to dietary advice post-transplant will be assessed in the intensive intervention group using
the following measures:
◦ 3-Day food diary: to assess change in dietary habits and adherence to change
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INTENT Study 2014 (Continued)
◦ Motivational assessment rulers: to assess motivation to change and elicit change (Miller/Rollnick
tools)
◦ Patient centred goals: assess if achieved individualised goals
◦ Review patient action plans: review of action steps taken
◦ Patient self-goal rating scale based on goal attainment scaling (GAS)
• Validity of bio-electrical impedance assessment as compared with gold standard body composition
analysis in kidney transplant recipients
• Cost-effectiveness analysis of intensive nutrition interventions versus standard of care to reduce weight
gain after kidney transplantation
• The difference in HbA1c between the groups will be used to determine the feasibility of undertaking a
larger study of nutrition interventions to improving glucose tolerance and reduce new-onset diabetes after
transplant (NODAT).
Starting date 03/03/2014
Contact information Dr Michael Collins
Department of Renal Medicine
Auckland City Hospital
Private Bag 92024
Auckland New Zealand Phone +64 9 3797440 Fax +64 9 3074987 Email michael.collins@adhb.govt.nz
Notes Contacted Principal Investigator to enquire about study progress and availability of results. Analysis of study
ongoing
59Dietary interventions for adults with chronic kidney disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D A T A A N D A N A L Y S E S
Comparison 1. Dietary intervention versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All-cause mortality 5 Risk Ratio (IV, Random, 95% CI) Subtotals only
1.1 Dietary counselling 4 371 Risk Ratio (IV, Random, 95% CI) 1.59 [0.60, 4.21]
1.2 CR-LIPE 1 170 Risk Ratio (IV, Random, 95% CI) 0.50 [0.22, 1.12]
2 Cardiovascular mortality 1 Risk Ratio (IV, Random, 95% CI) Totals not selected
2.1 Dietary counselling 1 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
3 Health-related quality of life
(SF-36) score
2 Mean Difference (IV, Random, 95% CI) Subtotals only
3.1 Dietary counselling 2 119 Mean Difference (IV, Random, 95% CI) 11.46 [7.73, 15.18]
4 End-stage kidney disease 2 232 Risk Ratio (M-H, Random, 95% CI) 0.53 [0.26, 1.07]
4.1 Dietary counselling 1 62 Risk Ratio (M-H, Random, 95% CI) 0.94 [0.06, 14.33]
4.2 CR-LIPE 1 170 Risk Ratio (M-H, Random, 95% CI) 0.51 [0.25, 1.05]
5 Doubling of serum creatinine 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
5.1 CR-LIPE 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
6 Employment 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
6.1 Dietary counselling 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
7 Dietary adherence 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
7.1 Dietary counselling 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
8 Worsening nutrition 2 Risk Ratio (IV, Random, 95% CI) Subtotals only
8.1 Dietary counselling 2 230 Risk Ratio (IV, Random, 95% CI) 0.40 [0.05, 3.37]
9 eGFR [mL/min/1.73 m2] 5 219 Std. Mean Difference (IV, Random, 95% CI) 1.08 [0.20, 1.97]
9.1 Dietary counselling 3 107 Std. Mean Difference (IV, Random, 95% CI) 1.41 [-0.40, 3.23]
9.2 Mediterranean 1 40 Std. Mean Difference (IV, Random, 95% CI) 0.23 [-0.39, 0.85]
9.3 Fruits and vegetables 1 72 Std. Mean Difference (IV, Random, 95% CI) 1.14 [0.64, 1.64]
10 Serum creatinine 3 112 Mean Difference (IV, Random, 95% CI) 0.83 [-16.57, 18.23]
10.1 Dietary counselling 2 72 Mean Difference (IV, Random, 95% CI) 1.79 [-24.47, 28.05]
10.2 Mediterranean 1 40 Mean Difference (IV, Random, 95% CI) -1.0 [-26.17, 24.17]
11 Systolic blood pressure 3 167 Mean Difference (IV, Random, 95% CI) -9.26 [-13.48, -5.04]
11.1 Dietary counselling 2 95 Mean Difference (IV, Random, 95% CI) -11.83 [-13.67, -9.
98]
11.2 Fruits and vegetables 1 72 Mean Difference (IV, Random, 95% CI) -7.10 [-9.60, -4.60]
12 Diastolic blood pressure 2 Mean Difference (IV, Random, 95% CI) Subtotals only
12.1 Dietary counselling 2 95 Mean Difference (IV, Random, 95% CI) -8.95 [-10.69, -7.21]
13 Energy intake 6 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
13.1 Dietary counselling 4 340 Std. Mean Difference (IV, Random, 95% CI) 1.54 [-0.87, 3.95]
13.2 Mediterranean diet 1 40 Std. Mean Difference (IV, Random, 95% CI) 1.86 [1.11, 2.61]
13.3 High nitrogen/low
carbohydrate
1 12 Std. Mean Difference (IV, Random, 95% CI) -0.65 [-1.82, 0.53]
14 Body weight 6 454 Mean Difference (IV, Random, 95% CI) -0.44 [-1.46, 0.58]
14.1 Dietary counselling 3 200 Mean Difference (IV, Random, 95% CI) -0.20 [-1.93, 1.53]
14.2 Fruits and vegetables 1 72 Mean Difference (IV, Random, 95% CI) -1.0 [-3.57, 1.57]
14.3 CR-LIPE 1 170 Mean Difference (IV, Random, 95% CI) -2.0 [-6.22, 2.22]
14.4 High nitrogen/low
carbohydrate
1 12 Mean Difference (IV, Random, 95% CI) 3.0 [-2.66, 8.66]
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15 BMI 2 Mean Difference (IV, Random, 95% CI) Subtotals only
15.1 Dietary counselling 2 119 Mean Difference (IV, Random, 95% CI) -1.70 [-5.23, 1.82]
16 Waist-hip ratio 1 Mean Difference (IV, Random, 95% CI) Totals not selected
16.1 Dietary counselling 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
17 Waist circumference, cm 1 Mean Difference (IV, Random, 95% CI) Totals not selected
17.1 Dietary counselling 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
18 Arm circumference 2 Mean Difference (IV, Random, 95% CI) Subtotals only
18.1 Dietary counselling 2 149 Mean Difference (IV, Random, 95% CI) 0.37 [-0.39, 1.12]
19 Serum albumin 6 541 Mean Difference (IV, Random, 95% CI) 0.16 [0.07, 0.24]
19.1 Dietary counselling 4 331 Mean Difference (IV, Random, 95% CI) 0.15 [0.14, 0.16]
19.2 Mediterranean 1 40 Mean Difference (IV, Random, 95% CI) 0.60 [0.11, 1.09]
19.3 CR-LIPE 1 170 Mean Difference (IV, Random, 95% CI) 0.0 [-0.20, 0.20]
20 Serum LDL cholesterol 2 Mean Difference (IV, Random, 95% CI) Totals not selected
20.1 Mediterranean diet 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
20.2 CR-LIPE 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 2. Mediterranean diet versus low fat
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Serum LDL cholesterol 1 Mean Difference (IV, Random, 95% CI) Totals not selected
Comparison 3. Fruits and vegetables versus bicarbonate
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 eGFR [mL/min/1.73 m2] 2 143 Mean Difference (IV, Random, 95% CI) 0.84 [-0.84, 2.53]
2 Serum creatinine 1 Mean Difference (IV, Random, 95% CI) Totals not selected
3 Systolic blood pressure 2 143 Mean Difference (IV, Random, 95% CI) -5.81 [-8.84, -2.77]
4 Body weight 2 143 Mean Difference (IV, Random, 95% CI) -5.09 [-7.73, -2.44]
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Analysis 1.1. Comparison 1 Dietary intervention versus control, Outcome 1 All-cause mortality.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 1 All-cause mortality
Study or subgroup Diet Control Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Flesher 2011 1/23 0/17 9.6 % 2.25 [ 0.10, 52.07 ]
Campbell 2008 4/32 0/32 11.4 % 9.00 [ 0.50, 160.59 ]
Sutton 2007 1/30 2/29 17.2 % 0.48 [ 0.05, 5.05 ]
Leon 2006 6/103 4/105 61.9 % 1.53 [ 0.44, 5.26 ]
Subtotal (95% CI) 188 183 100.0 % 1.59 [ 0.60, 4.21 ]
Total events: 12 (Diet), 6 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.43, df = 3 (P = 0.49); I2 =0.0%
Test for overall effect: Z = 0.94 (P = 0.35)
2 CR-LIPE
Facchini 2003 8/91 14/79 100.0 % 0.50 [ 0.22, 1.12 ]
Subtotal (95% CI) 91 79 100.0 % 0.50 [ 0.22, 1.12 ]
Total events: 8 (Diet), 14 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.69 (P = 0.092)
0.005 0.1 1 10 200
Less with diet Less with control
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Analysis 1.2. Comparison 1 Dietary intervention versus control, Outcome 2 Cardiovascular mortality.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 2 Cardiovascular mortality
Study or subgroup Diet Control Risk Ratio Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Campbell 2008 3/32 0/30 6.58 [ 0.35, 122.21 ]
0.005 0.1 1 10 200
Less with diet Less with control
Analysis 1.3. Comparison 1 Dietary intervention versus control, Outcome 3 Health-related quality of life
(SF-36) score.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 3 Health-related quality of life (SF-36) score
Study or subgroup Diet Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Tzvetanov 2014 9 58.3 (13) 8 43.6 (22) 4.6 % 14.70 [ -2.75, 32.15 ]
Zhou 2011b 52 60.1 (11.2) 50 48.8 (8.3) 95.4 % 11.30 [ 7.48, 15.12 ]
Subtotal (95% CI) 61 58 100.0 % 11.46 [ 7.73, 15.18 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.14, df = 1 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 6.02 (P < 0.00001)
Test for subgroup differences: Not applicable
-50 -25 0 25 50
Better with control Better with diet
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Analysis 1.4. Comparison 1 Dietary intervention versus control, Outcome 4 End-stage kidney disease.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 4 End-stage kidney disease
Study or subgroup Diet Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Dietary counselling
Campbell 2008 1/32 1/30 6.5 % 0.94 [ 0.06, 14.33 ]
Subtotal (95% CI) 32 30 6.5 % 0.94 [ 0.06, 14.33 ]
Total events: 1 (Diet), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.05 (P = 0.96)
2 CR-LIPE
Facchini 2003 10/91 17/79 93.5 % 0.51 [ 0.25, 1.05 ]
Subtotal (95% CI) 91 79 93.5 % 0.51 [ 0.25, 1.05 ]
Total events: 10 (Diet), 17 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.83 (P = 0.068)
Total (95% CI) 123 109 100.0 % 0.53 [ 0.26, 1.07 ]
Total events: 11 (Diet), 18 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.18, df = 1 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 1.78 (P = 0.075)
Test for subgroup differences: Chi2 = 0.18, df = 1 (P = 0.67), I2 =0.0%
0.02 0.1 1 10 50
Less with diet Less with control
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Analysis 1.5. Comparison 1 Dietary intervention versus control, Outcome 5 Doubling of serum creatinine.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 5 Doubling of serum creatinine
Study or subgroup Diet Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 CR-LIPE
Facchini 2003 19/91 31/79 0.53 [ 0.33, 0.86 ]
0.2 0.5 1 2 5
Lower risk with diet Lower risk with control
Analysis 1.6. Comparison 1 Dietary intervention versus control, Outcome 6 Employment.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 6 Employment
Study or subgroup Diet Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Dietary counselling
Tzvetanov 2014 7/9 1/8 6.22 [ 0.96, 40.22 ]
0.02 0.1 1 10 50
More with control More with diet
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Analysis 1.7. Comparison 1 Dietary intervention versus control, Outcome 7 Dietary adherence.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 7 Dietary adherence
Study or subgroup Diet Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Dietary counselling
Riccio 2014 19/27 12/27 1.58 [ 0.97, 2.58 ]
0.2 0.5 1 2 5
Improves with control Improves with diet
Analysis 1.8. Comparison 1 Dietary intervention versus control, Outcome 8 Worsening nutrition.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 8 Worsening nutrition
Study or subgroup Diet Control Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Campbell 2008 0/24 6/26 32.9 % 0.08 [ 0.00, 1.40 ]
Leon 2006 7/86 9/94 67.1 % 0.85 [ 0.33, 2.18 ]
Subtotal (95% CI) 110 120 100.0 % 0.40 [ 0.05, 3.37 ]
Total events: 7 (Diet), 15 (Control)
Heterogeneity: Tau2 = 1.55; Chi2 = 2.34, df = 1 (P = 0.13); I2 =57%
Test for overall effect: Z = 0.85 (P = 0.40)
Test for subgroup differences: Not applicable
0.002 0.1 1 10 500
Less with diet Less with control
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Analysis 1.9. Comparison 1 Dietary intervention versus control, Outcome 9 eGFR [mL/min/1.73 m2].
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 9 eGFR [mL/min/1.73 m
2
]
Study or subgroup Diet Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Tzvetanov 2014 9 55.5 (18.6) 8 38.8 (18.9) 17.9 % 0.85 [ -0.16, 1.85 ]
Flesher 2011 23 -1.2 (3) 17 -11.2 (3) 18.1 % 3.27 [ 2.29, 4.25 ]
Campbell 2008 24 22.9 (6.8) 26 21.4 (7.2) 21.4 % 0.21 [ -0.35, 0.77 ]
Subtotal (95% CI) 56 51 57.4 % 1.41 [ -0.40, 3.23 ]
Heterogeneity: Tau2 = 2.37; Chi2 = 28.27, df = 2 (P<0.00001); I2 =93%
Test for overall effect: Z = 1.53 (P = 0.13)
2 Mediterranean
Mekki 2010 20 77 (9) 20 75 (8) 20.9 % 0.23 [ -0.39, 0.85 ]
Subtotal (95% CI) 20 20 20.9 % 0.23 [ -0.39, 0.85 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.73 (P = 0.47)
3 Fruits and vegetables
Goraya 2014 36 36.9 (6.7) 36 28.8 (7.3) 21.7 % 1.14 [ 0.64, 1.64 ]
Subtotal (95% CI) 36 36 21.7 % 1.14 [ 0.64, 1.64 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.48 (P < 0.00001)
Total (95% CI) 112 107 100.0 % 1.08 [ 0.20, 1.97 ]
Heterogeneity: Tau2 = 0.87; Chi2 = 33.55, df = 4 (P<0.00001); I2 =88%
Test for overall effect: Z = 2.41 (P = 0.016)
Test for subgroup differences: Chi2 = 5.47, df = 2 (P = 0.06), I2 =63%
-4 -2 0 2 4
Higher with control Higher with diet
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Analysis 1.10. Comparison 1 Dietary intervention versus control, Outcome 10 Serum creatinine.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 10 Serum creatinine
Study or subgroup Diet Control
Mean
Difference Weight
Mean
Difference
N
Mean(SD)[
mol/L] N
Mean(SD)[
mol/L] IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Tzvetanov 2014 9 124.6 (45) 8 142.3 (47.7) 15.5 % -17.70 [ -61.94, 26.54 ]
Chanwikrai 2012 28 183 (75) 27 172 (19) 36.8 % 11.00 [ -17.69, 39.69 ]
Subtotal (95% CI) 37 35 52.2 % 1.79 [ -24.47, 28.05 ]
Heterogeneity: Tau2 = 50.01; Chi2 = 1.14, df = 1 (P = 0.29); I2 =12%
Test for overall effect: Z = 0.13 (P = 0.89)
2 Mediterranean
Mekki 2010 20 109 (47) 20 110 (33) 47.8 % -1.00 [ -26.17, 24.17 ]
Subtotal (95% CI) 20 20 47.8 % -1.00 [ -26.17, 24.17 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.08 (P = 0.94)
Total (95% CI) 57 55 100.0 % 0.83 [ -16.57, 18.23 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.18, df = 2 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 0.09 (P = 0.93)
Test for subgroup differences: Chi2 = 0.02, df = 1 (P = 0.88), I2 =0.0%
-100 -50 0 50 100
Lower with diet Lower with control
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Analysis 1.11. Comparison 1 Dietary intervention versus control, Outcome 11 Systolic blood pressure.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 11 Systolic blood pressure
Study or subgroup Diet Control
Mean
Difference Weight
Mean
Difference
N
Mean(SD)[mm
Hg] N
Mean(SD)[mm
Hg] IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Chanwikrai 2012 28 132.21 (19.04) 27 138.94 (19.41) 12.8 % -6.73 [ -16.90, 3.44 ]
Flesher 2011 23 -9 (3) 17 3 (3) 45.1 % -12.00 [ -13.88, -10.12 ]
Subtotal (95% CI) 51 44 57.8 % -11.83 [ -13.67, -9.98 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.00, df = 1 (P = 0.32); I2 =0.0%
Test for overall effect: Z = 12.53 (P < 0.00001)
2 Fruits and vegetables
Goraya 2014 36 128.3 (4.5) 36 135.4 (6.2) 42.2 % -7.10 [ -9.60, -4.60 ]
Subtotal (95% CI) 36 36 42.2 % -7.10 [ -9.60, -4.60 ]
Heterogeneity: not applicable
Test for overall effect: Z = 5.56 (P < 0.00001)
Total (95% CI) 87 80 100.0 % -9.26 [ -13.48, -5.04 ]
Heterogeneity: Tau2 = 9.35; Chi2 = 9.86, df = 2 (P = 0.01); I2 =80%
Test for overall effect: Z = 4.30 (P = 0.000017)
Test for subgroup differences: Chi2 = 8.86, df = 1 (P = 0.00), I2 =89%
-20 -10 0 10 20
Lower with diet Lower with control
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Analysis 1.12. Comparison 1 Dietary intervention versus control, Outcome 12 Diastolic blood pressure.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 12 Diastolic blood pressure
Study or subgroup Diet Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Chanwikrai 2012 28 66.5 (8.55) 27 75.14 (9.06) 14.0 % -8.64 [ -13.30, -3.98 ]
Flesher 2011 23 -11 (3) 17 -2 (3) 86.0 % -9.00 [ -10.88, -7.12 ]
Subtotal (95% CI) 51 44 100.0 % -8.95 [ -10.69, -7.21 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 10.06 (P < 0.00001)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
Lower with diet Lower with control
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Analysis 1.13. Comparison 1 Dietary intervention versus control, Outcome 13 Energy intake.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 13 Energy intake
Study or subgroup Diet Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Leon 2006 86 333 (70) 94 -47 (66) 24.9 % 5.57 [ 4.92, 6.22 ]
Campbell 2008 24 114.5 (25.6) 26 102.7 (22.2) 25.0 % 0.49 [ -0.08, 1.05 ]
Sutton 2007 26 0.12 (6.7) 23 -1.5 (5.8) 25.0 % 0.25 [ -0.31, 0.82 ]
Orazio 2011 37 6337 (10546) 24 7630 (9083) 25.1 % -0.13 [ -0.64, 0.39 ]
Subtotal (95% CI) 173 167 100.0 % 1.54 [ -0.87, 3.95 ]
Heterogeneity: Tau2 = 5.99; Chi2 = 215.62, df = 3 (P<0.00001); I2 =99%
Test for overall effect: Z = 1.25 (P = 0.21)
2 Mediterranean diet
Mekki 2010 20 7.6 (0.5) 20 6.1 (1) 100.0 % 1.86 [ 1.11, 2.61 ]
Subtotal (95% CI) 20 20 100.0 % 1.86 [ 1.11, 2.61 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.83 (P < 0.00001)
3 High nitrogen/low carbohydrate
Whittier 1985 6 1941 (122) 6 2097 (291) 100.0 % -0.65 [ -1.82, 0.53 ]
Subtotal (95% CI) 6 6 100.0 % -0.65 [ -1.82, 0.53 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.08 (P = 0.28)
Test for subgroup differences: Chi2 = 12.48, df = 2 (P = 0.00), I2 =84%
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Analysis 1.14. Comparison 1 Dietary intervention versus control, Outcome 14 Body weight.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 14 Body weight
Study or subgroup Diet Control
Mean
Difference Weight
Mean
Difference
N Mean(SD)[kg] N Mean(SD)[kg] IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Campbell 2008 24 73.8 (15.7) 26 77.4 (20.1) 1.0 % -3.60 [ -13.56, 6.36 ]
Sutton 2007 25 2.3 (3.5) 23 1.1 (3.6) 20.3 % 1.20 [ -0.81, 3.21 ]
Orazio 2011 56 -1.58 (0.04) 46 -0.7 (3) 56.4 % -0.88 [ -1.75, -0.01 ]
Subtotal (95% CI) 105 95 77.7 % -0.20 [ -1.93, 1.53 ]
Heterogeneity: Tau2 = 1.09; Chi2 = 3.82, df = 2 (P = 0.15); I2 =48%
Test for overall effect: Z = 0.23 (P = 0.82)
2 Fruits and vegetables
Goraya 2014 36 80.2 (5.1) 36 81.2 (6) 13.6 % -1.00 [ -3.57, 1.57 ]
Subtotal (95% CI) 36 36 13.6 % -1.00 [ -3.57, 1.57 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.76 (P = 0.45)
3 CR-LIPE
Facchini 2003 91 76 (14) 79 78 (14) 5.5 % -2.00 [ -6.22, 2.22 ]
Subtotal (95% CI) 91 79 5.5 % -2.00 [ -6.22, 2.22 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.93 (P = 0.35)
4 High nitrogen/low carbohydrate
Whittier 1985 6 68 (5) 6 65 (5) 3.2 % 3.00 [ -2.66, 8.66 ]
Subtotal (95% CI) 6 6 3.2 % 3.00 [ -2.66, 8.66 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.04 (P = 0.30)
Total (95% CI) 238 216 100.0 % -0.44 [ -1.46, 0.58 ]
Heterogeneity: Tau2 = 0.29; Chi2 = 5.90, df = 5 (P = 0.32); I2 =15%
Test for overall effect: Z = 0.84 (P = 0.40)
Test for subgroup differences: Chi2 = 2.20, df = 3 (P = 0.53), I2 =0.0%
-20 -10 0 10 20
Lower with diet Lower with control
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Analysis 1.15. Comparison 1 Dietary intervention versus control, Outcome 15 BMI.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 15 BMI
Study or subgroup Diet Control
Mean
Difference Weight
Mean
Difference
N Mean(SD)[kg/m2] N Mean(SD)[kg/m2] IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Tzvetanov 2014 9 41.1 (5.4) 8 46.3 (9.3) 20.9 % -5.20 [ -12.55, 2.15 ]
Orazio 2011 56 -1.53 (12.2) 46 -0.75 (0.99) 79.1 % -0.78 [ -3.99, 2.43 ]
Subtotal (95% CI) 65 54 100.0 % -1.70 [ -5.23, 1.82 ]
Heterogeneity: Tau2 = 1.40; Chi2 = 1.17, df = 1 (P = 0.28); I2 =14%
Test for overall effect: Z = 0.95 (P = 0.34)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
Lower with diet Lower with control
Analysis 1.16. Comparison 1 Dietary intervention versus control, Outcome 16 Waist-hip ratio.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 16 Waist-hip ratio
Study or subgroup Diet Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Orazio 2011 45 -2.08 (12.5) 37 -1.03 (10) -1.05 [ -5.92, 3.82 ]
-10 -5 0 5 10
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Analysis 1.17. Comparison 1 Dietary intervention versus control, Outcome 17 Waist circumference, cm.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 17 Waist circumference, cm
Study or subgroup Diet Control
Mean
Difference
Mean
Difference
N Mean(SD)[cm] N Mean(SD)[cm] IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Orazio 2011 45 -2.52 (1.45) 37 -2.06 (4.77) -0.46 [ -2.05, 1.13 ]
-4 -2 0 2 4
Decreases with diet Decreases with control
Analysis 1.18. Comparison 1 Dietary intervention versus control, Outcome 18 Arm circumference.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 18 Arm circumference
Study or subgroup Diet Control
Mean
Difference Weight
Mean
Difference
N Mean(SD)[cm] N Mean(SD)[cm] IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Sutton 2007 25 0.47 (2) 22 0.44 (2.1) 40.9 % 0.03 [ -1.15, 1.21 ]
Zhou 2011b 52 17.9 (2.9) 50 17.3 (2.1) 59.1 % 0.60 [ -0.38, 1.58 ]
Subtotal (95% CI) 77 72 100.0 % 0.37 [ -0.39, 1.12 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.53, df = 1 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 0.95 (P = 0.34)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
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Analysis 1.19. Comparison 1 Dietary intervention versus control, Outcome 19 Serum albumin.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 19 Serum albumin
Study or subgroup Diet Control
Mean
Difference Weight
Mean
Difference
N Mean(SD)[g/dL] N Mean(SD)[g/dL] IV,Random,95% CI IV,Random,95% CI
1 Dietary counselling
Sutton 2007 24 0 (3.2) 22 -0.55 (3.2) 0.2 % 0.55 [ -1.30, 2.40 ]
Campbell 2008 24 4 (0.5) 26 3.7 (0.5) 8.1 % 0.30 [ 0.02, 0.58 ]
Chanwikrai 2012 28 4.31 (0.44) 27 4.15 (0.21) 16.0 % 0.16 [ -0.02, 0.34 ]
Leon 2006 86 0.21 (0.04) 94 0.06 (0.03) 58.9 % 0.15 [ 0.14, 0.16 ]
Subtotal (95% CI) 162 169 83.1 % 0.15 [ 0.14, 0.16 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.31, df = 3 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 28.37 (P < 0.00001)
2 Mediterranean
Mekki 2010 20 4.4 (0.5) 20 3.8 (1) 2.8 % 0.60 [ 0.11, 1.09 ]
Subtotal (95% CI) 20 20 2.8 % 0.60 [ 0.11, 1.09 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.40 (P = 0.016)
3 CR-LIPE
Facchini 2003 91 4.1 (0.6) 79 4.1 (0.7) 14.0 % 0.0 [ -0.20, 0.20 ]
Subtotal (95% CI) 91 79 14.0 % 0.0 [ -0.20, 0.20 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Total (95% CI) 273 268 100.0 % 0.16 [ 0.07, 0.24 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 6.77, df = 5 (P = 0.24); I2 =26%
Test for overall effect: Z = 3.61 (P = 0.00030)
Test for subgroup differences: Chi2 = 5.46, df = 2 (P = 0.07), I2 =63%
-4 -2 0 2 4
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Analysis 1.20. Comparison 1 Dietary intervention versus control, Outcome 20 Serum LDL cholesterol.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 1 Dietary intervention versus control
Outcome: 20 Serum LDL cholesterol
Study or subgroup Diet Control
Mean
Difference
Mean
Difference
N Mean(SD)[mmol/L] N Mean(SD)[mmol/L] IV,Random,95% CI IV,Random,95% CI
1 Mediterranean diet
Mekki 2010 20 2 (0.9) 20 3 (0.9) -1.00 [ -1.56, -0.44 ]
2 CR-LIPE
Facchini 2003 100 3.68 (1.01) 48 3.47 (1.99) 0.21 [ -0.39, 0.81 ]
-2 -1 0 1 2
Lower with diet Lower with control
Analysis 2.1. Comparison 2 Mediterranean diet versus low fat, Outcome 1 Serum LDL cholesterol.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 2 Mediterranean diet versus low fat
Outcome: 1 Serum LDL cholesterol
Study or subgroup Mediterranean Low fat
Mean
Difference
Mean
Difference
N Mean(SD)[mmol/L] N Mean(SD)[mmol/L] IV,Random,95% CI IV,Random,95% CI
Stachowska 2005 21 2.9 (0.85) 17 3.5 (0.88) -0.60 [ -1.15, -0.05 ]
-2 -1 0 1 2
Lower with Mediterranean Lower with low fat
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Analysis 3.1. Comparison 3 Fruits and vegetables versus bicarbonate, Outcome 1 eGFR [mL/min/1.73 m2].
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 3 Fruits and vegetables versus bicarbonate
Outcome: 1 eGFR [mL/min/1.73 m
2
]
Study or subgroup Fruits and vegetables Bicarbonate
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Goraya 2014 36 36.9 (6.7) 36 35.2 (6.9) 28.7 % 1.70 [ -1.44, 4.84 ]
Goraya 2013 36 21.9 (5.1) 35 21.4 (3.3) 71.3 % 0.50 [ -1.49, 2.49 ]
Total (95% CI) 72 71 100.0 % 0.84 [ -0.84, 2.53 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.40, df = 1 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 0.98 (P = 0.33)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Higher with bicarbonate Higher with fruit and veg
Analysis 3.2. Comparison 3 Fruits and vegetables versus bicarbonate, Outcome 2 Serum creatinine.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 3 Fruits and vegetables versus bicarbonate
Outcome: 2 Serum creatinine
Study or subgroup Fruits and vegetables Bicarbonate
Mean
Difference
Mean
Difference
N
Mean(SD)[
mol/L] N
Mean(SD)[
mol/L] IV,Random,95% CI IV,Random,95% CI
Goraya 2013 36 362 (88) 35 371 (27) -9.00 [ -39.11, 21.11 ]
-50 -25 0 25 50
Lower with fruits and veg Lower with bicarbonate
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Analysis 3.3. Comparison 3 Fruits and vegetables versus bicarbonate, Outcome 3 Systolic blood pressure.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 3 Fruits and vegetables versus bicarbonate
Outcome: 3 Systolic blood pressure
Study or subgroup Fruits and vegetables Bicarbonate
Mean
Difference Weight
Mean
Difference
N
Mean(SD)[mm
Hg] N
Mean(SD)[mm
Hg] IV,Random,95% CI IV,Random,95% CI
Goraya 2014 36 128.3 (4.5) 36 135.7 (4.5) 48.6 % -7.40 [ -9.48, -5.32 ]
Goraya 2013 36 131.7 (3.3) 35 136 (4.4) 51.4 % -4.30 [ -6.11, -2.49 ]
Total (95% CI) 72 71 100.0 % -5.81 [ -8.84, -2.77 ]
Heterogeneity: Tau2 = 3.81; Chi2 = 4.85, df = 1 (P = 0.03); I2 =79%
Test for overall effect: Z = 3.75 (P = 0.00018)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Lower with fruits and veg Lower with bicarbonate
Analysis 3.4. Comparison 3 Fruits and vegetables versus bicarbonate, Outcome 4 Body weight.
Review: Dietary interventions for adults with chronic kidney disease
Comparison: 3 Fruits and vegetables versus bicarbonate
Outcome: 4 Body weight
Study or subgroup Fruits and vegetables Bicarbonate
Mean
Difference Weight
Mean
Difference
N Mean(SD)[kg] N Mean(SD)[kg] IV,Random,95% CI IV,Random,95% CI
Goraya 2014 36 80.2 (5.1) 36 83.9 (5.9) 48.7 % -3.70 [ -6.25, -1.15 ]
Goraya 2013 36 78 (5.3) 35 84.4 (5) 51.3 % -6.40 [ -8.80, -4.00 ]
Total (95% CI) 72 71 100.0 % -5.09 [ -7.73, -2.44 ]
Heterogeneity: Tau2 = 2.05; Chi2 = 2.29, df = 1 (P = 0.13); I2 =56%
Test for overall effect: Z = 3.77 (P = 0.00016)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Lower with fruits and veg Lower with bicarbonate
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A D D I T I O N A L T A B L E S
Table 1. Summary of included studies
Study ID Treatment Control CKD
stage
GFR (mL/
min)
Mean age % men Mean GFR
(mL/min)
Mean BMI
(kg/m2)
Detailed
inclusion
criteria
Counselling
Campbell
2008
Dietary
coun-
selling
Written
material
4-5 ≤ 30 69.5 (11.
7)
70.9 (11.
6)
61 23.1 (7.2)
21.6 (6.1)
26.8 (4.7)
27.6 (5.2)
> 18 years;
eGFR < 30
mL/
min/1.73 m
2; CKD not
previously
seen by a
dietitian for
stage
4 CKD; ab-
sence
of commu-
nication or
intellec-
tual impair-
ment;
absence
of malnutri-
tion from a
cause other
than CKD;
not ex-
pected to re-
quire
RRT within
6 months
Chan-
wikrai
2012
Dietary
coun-
selling
Standard
care
3-5 -- -- -- -- -- CKD stage
3-5
Flesher
2011
Dietary
coun-
selling +
exercise
Standard
care
3-4 20-60 63.4 (12.
1)
63.4 (11.
8)
53 37.2 (3.2)
38.4 (3.0)
-- eGFR 20 to
60
mL/min for
≥3 months;
presence of
urinary pro-
tein; adult
(≥ 19 years)
; hyperten-
sion or tak-
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Table 1. Summary of included studies (Continued)
ing at least
1 antihyper-
ten-
sive medica-
tion; physi-
cian ap-
proval to ex-
ercise
Leon 2006 Dietary
coun-
selling
and target-
ing nutri-
tional bar-
riers
Standard
care
5 (HD) Dialysis 62
60
42 -- 29.0
27.9
18 to
85 years; re-
ceiving dial-
ysis
for at least 9
months;
mean serum
al-
bumin level
for previous
3 months <
3.70 g/
dL (brom-
cresol green
method) or
< 3.40 g/
dL (brom-
cresol pur-
plemethod)
Orazio
2011
Dietary
coun-
selling
Standard
care
Transplant Transplant 54.9 (9.9)
54.7 (11.
8)
61 54 (20)
48 (17)
29 (5)
29 (6)
Kidney
transplant >
6 months
Riccio
2014
Dietary
coun-
selling
Low pro-
tein diet
-- -- -- -- -- -- CKD
not requir-
ing dialysis
Sutton
2007
Dietary
coun-
selling
+ physical
activity
Standard
care
5 (PD) Dialysis 60.7 (15.
5)
58.5 (15.
4)
55 -- 25.4 (3.8)
25.7 (3.4)
Treat-
ment with
CAPD for 3
months or
longer; not
diabetic
Teng 2013 Dietary
coun-
selling +
exercise
Standard
care
1-3 -- 62.1 (14.
0)
65.7 (11.
2)
71 53.7 (18.3)
49.5 (13.3)
24.4 (3.9)
25.3 (3.1)
20 years or
older; com-
municate in
Mandarin
or
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Table 1. Summary of included studies (Continued)
Taiwanese;
aware of
CKD diag-
nosis; GFR
range 30 to
106.7 mL/
min/1.73 m
2
Tzvetanov
2014
Dietary
coun-
selling +
exercise
Standard
care
Transplant Transplant 46 (6.9)
45 (19)
47 -- -- Kidney
transplant;
obese
Zhou
2011b
Dietary
coun-
selling
Standard
care
5 (PD) Dialysis 57.8 (12.
8)
59.9 (13.
6)
71 -- 23.3 (4.5)
22.8 (6.2)
18
to 70 years;
receiving
long-term
dialysis > 3
months
Mediterranean diet
DIRECT
Study
2013
Mediter-
ranean diet
(restricted
calorie)
Low-fat
(restricted
calorie)
diet
Low-
carbohy-
drate (un-
restricted
calorie)
diet
3 30-60 52.5 (6.2) 99 52.6 (5.9) 30.9 (3.4) 40
to 65 years
withBMI≥
27 kg/m
2; individu-
alswith type
2 diabetes
or coronary
heart
disease were
eligible re-
gardless
of age. Post-
hoc analysis
among par-
tic-
ipants with
eGFR 30 to
60 mL/
min/1.73 m
2
Mekki
2010
Mediter-
ranean diet
Standard
care
2-3 60-89 60 (10)
59 (12)
53 70 (10)
75 (15)
26.9 (3.9)
25.1 (4.2)
eGFR 60 to
89 mL/
min/1.
73 m2; dys-
lipidaemia
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Table 1. Summary of included studies (Continued)
Sta-
chowska
2005
Modified
Mediter-
ranean diet
Low fat
diet
Transplant Transplant 41 (12.5)
46
(9.5)
68 -- 25.0 (4.1)
26.2 (4.2)
Stable
transplant
function
Increased fruit and vegetables
Goraya
2013
Increased
fruit and
vegetable
intake
Oral bicar-
bonate
4 15-29 53.9 (6.9)
54.2 (5.3)
54 22.8 (4.9)
23.0 (3.5)
-- Non-malig-
nant hyper-
tension;
eGFR 15 to
29 mL/
min/1.73 m
2; plasma
TCO2< 22
mM; no di-
a-
betes or car-
diovascular
disease; two
or more pri-
mary
care physi-
cian visits in
previous
year; age ≥
18 years
Goraya
2014
Increased
fruit and
vegetable
intake
Oral bicar-
bonate
Standard
care
3 30-59 53.5 (5.2)
53.9 (4.8)
44 42.3 (7.1)
42.6 (7.6)
-- Non-ma-
lignant hy-
pertension,
eGFR 30
to 59 mL/
min/1.73
m2; plasma
TCO2<
25 mM;
macroalbu-
minuria;
able to
tolerate an-
giotensin-
converting
inhibition;
non-smok-
ing for ≥
1 year; no
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Table 1. Summary of included studies (Continued)
diabetes
or cardio-
vascular
disease; 2
or more
primary
care physi-
cian visits
in previous
year; ≥ 18
years
Carbohydrate-restricted, low-iron, polyphenol enriched (CR-LIPE) diet
Facchini
2003
CR-LIPE
diet
Protein re-
striction
2-5 15-75 59 (10)
60 (12)
51 64 (28)
62 (32)
28 (5)
28 (5)
Type 2
diabetes; re-
ferred
to nephrol-
ogy clinic
for kidney
failure (15
± 75 mL/
min); other-
wise unex-
plained pro-
teinuria
(350 ± 12,
000 mg/d);
kidney dis-
ease at-
tributed to
diabetes
High-nitrogen, low-carbohydrate diet
Whittier
1985
High-ni-
trogen, low
carbohy-
drate diet
Standard
care
Transplant Transplant 33
32
75 -- -- Kidney
transplant;
no diabetes
BMI - bodymass index; CAPD - continuous ambulatory peritoneal dialysis; CKD - chronic kidney disease; eGFR - estimated glomerular
filtration rate; HD - haemodialysis; PD - peritoneal dialysis; RRT - renal replacement therapy; TCO2 - total carbon dioxide
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Table 2. TIDieR framework of intervention descriptions for included studies
Study ID Materials Dietary intervention Adherence
Why What Who How Where When
and how
much
Tailoring Modifi-
cation
Planned Actual
Counselling
Campbell
2008
To de-
termine
whether
indi-
vidual
nutrition
coun-
selling
improves
body
compo-
sition,
energy
intake,
and nu-
tritional
status
Individ-
ualised
dietary
prescrip-
tion (in-
cluding
energy
(125 to
146 kJ/
kg/d) and
protein
(0.75 to
1.0 g/kg/
d)) incor-
porating
KDOQI
recom-
menda-
tions to
provide
intensive
nutri-
tional
coun-
selling
with
regular
monitor-
ing
Dietitian Face-to-
face, tele-
phone,
individu-
alised
-- Baseline
for 60
min; then
biweekly
for 1st
month
(15 to 30
min);
then
weekly
till end of
study pe-
riod
Depend-
ing on
dietary
require-
ments,
diet was
tailored
following
clinical
data and
initial
interview.
Delivery
was
guided
by the
medical
nutrition
therapy
frame-
work
from the
American
Dietetic
Associa-
tion
Self-man-
agement
prin-
ciples:
goal-
setting,
menu
planning,
label
reading,
and iden-
tification
of foods
con-
taining
protein,
sodium,
and
so on,
depend-
ing on
require-
ments
Dietary
intake as-
sessed us-
ing 3-day
food
record,
verified
by the di-
etitian.
Strategies
to im-
prove ad-
her-
ence or fi-
delity not
reported
No pa-
tient vol-
untarily
withdrew
from the
study
Chan-
wikrai
2012
Changes
of
diet and
lifestyle
can
slow pro-
gression
of CKD
Dietary
modifica-
tion with
or with-
out exer-
cise by an
empow-
erment
approach
(includ-
-- -- -- -- -- -- - 81 (96%)
com-
pleted the
study
program
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Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
ing low
protein 0.
6 to 0.8 g/
kg/d) and
low salt (5
g/d)
Flesher
2011
To deter-
mine
whether
addi-
tional of
cooking
and exer-
cise
classes
would
slow pro-
gression
of CKD
Indi-
vidual
nutrition
coun-
selling on
moderate
protein
and low
sodium,
with
individ-
ualised
modifi-
cation of
potas-
sium
and/or
phos-
phate
plus a
group
nutrition
class,
cooking
classes
with a
dietitian
and cook
educa-
tion,
CKD
cook-
book,
shopping
tour, and
12-week
exercise
program
led by a
Certified
Exercise
Cook-
ing class -
dieti-
tian and
cook edu-
cator; Ex-
ercise
- exercise
physiol-
ogist and
nurse
Face-to-
face; indi-
vidual
and
group ses-
sions
Exercise
class took
place in
well-
equipped
gym
at Garatt
Wellness
Centre:
details re-
gard-
ing cook-
ing class
not pro-
vided
Cooking
classes
over 4
weeks for
2 hour
session,
shopping
tour;
Exercise
class at
Garratt
Wellness
centre, 3
x 1 hour
session/
week
with
strength
training,
flexibility
compo-
nents,
resistance
training
Skills for
tailoring
and mod-
ifying
diet and
lifestyle
were pro-
vided.
Diet his-
tory was
dis-
cussed in
detail at
the indi-
vidual ap-
point-
ments
Self-
manage-
ment fo-
cus in us-
ing goal-
set-
ting and
build-
ing confi-
dence in
the man-
agement
of disease
Adher-
ence to
exercise
was as-
sessed by
physical
activity
readiness
question-
naire and
6 minute
submax-
imal
walk test;
biochem-
ical and
clinical
param-
eters
related to
cardio-
vascular
health;
moni-
tored at
baseline,
6 months
and 12
months
Overall,
the exper-
imen-
tal group
showed
‘improve-
ment”
in their
exercise
fre-
quency,
concern
over
health
condi-
tion, and
frequency
of visits
to health
providers
or hospi-
talisation;
also 20
versus 83
improved
end-
points in
control
group
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Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
Physiolo-
gist and
nurse.
Exercise
program
started
after 6
months
Leon
2006
Whether
targeting
spe-
cific nu-
tritional
barriers
will im-
prove al-
bumin
levels
Study
coordina-
tors ab-
stracted
medical
records
and in-
terviewed
partici-
pants to
deter-
mine the
presence
of 10
specific
nutri-
tional
barriers
(nutri-
tional
knowl-
edge,
appetite,
help
needed
with
cooking
and shop-
ping,
low fluid
intake,
dialysis
dose, de-
pression,
difficulty
chewing,
difficulty
swal-
lowing,
Study co-
ordina-
tors;
dietitians
Face-to-
face; indi-
vidu-
alised
During
dialysis
sessions
During
the next
12
months,
study co-
ordina-
tors met
monthly
with pa-
tients to
rein-
force rec-
ommen-
dations,
monitor
progress,
and
answer
ques-
tions.
Study co-
ordina-
tors
also up-
dated pa-
tients’ di-
etitians
monthly
Tailored
to specific
nutri-
tional
barri-
ers identi-
fied dur-
ing inter-
views
Specific
to nutri-
tional
barriers
-- --
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Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
gastroin-
testinal
symp-
toms,
acidosis)
. Study
coordi-
nators
educated
all inter-
vention
patients
about
the
meaning
and im-
portance
of good
nutri-
tional
status.
They
then
provided
feedback
and rec-
ommen-
dations
to inter-
vention
patients.
The
informa-
tion was
provided
during a
dialysis
treatment
and
tailored
to the
specific
barriers
present.
Study
coordina-
tors also
commu-
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Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
nicated
infor-
mation
about
barriers
to facility
dietitians
and mod-
ified rec-
ommen-
dations
based on
feedback
from
these
dietitians.
Facility
dietitians
were
asked to
reinforce
study
coordina-
tor rec-
ommen-
dations
when
they met
with their
study
patients
Orazio
2011
To inves-
tigate the
effect of
dietitian
involve-
ment in a
multidis-
ciplinary
lifestyle
interven-
tion com-
paring
risk factor
modifica-
tion for
cardio-
vascular
Individ-
ualised
dietary
advice
was
provided
to par-
ticipants
for the
duration
of the
study.
Achieve-
ment
and/or
mainte-
nance of
Multidis-
ciplinary
team
(nephrol-
ogist, di-
etitian,
nurse, en-
docrinol-
ogist)
Individu-
alised ad-
vice from
nephrol-
ogist, di-
etitian,
nurse and
endocri-
nolo-
gist (indi-
vidual or
group)
Multiple
locations
and
settings
including
during
routine
trans-
plant
care, out-
patient
dietetic
and
nursing
care, and
routine
Bi-
monthly
reviews
for 2
years by
nephrol-
ogist;
4-week
initial
program
from
dietitian
with bi-
monthly
reviews
for 2
Dieti-
tian deliv-
ery of in-
dividual
diet ini-
tially and
then indi-
vid-
ualist di-
etetic re-
views in-
cluding
weight,
waist cir-
cumfer-
ence and
Specific
to patient
and an-
thropo-
morphic
measure-
ments
during
follow-up
-- 8/96 par-
ticipants
chose to
withdraw
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disease
with
standard
post-
trans-
plant care
in kidney
trans-
plant
recipients
with
abnormal
glucose
tolerance
a healthy
weight
(BMI),
20 to 25
kg/m2)
was the
primary
goal of
nutrition
therapy
using a
Mediter-
ranean-
style (<
30% total
energy
from
fat), low
GI diet. A
moderate
energy
deficit of
500 kcal/
d (2,000
kJ/d) to
promote
0.5 kg of
weight
loss/week
was used.
Study
materials
used to
teach par-
ticipants
included
a study
manual
with di-
etary and
lifestyle
informa-
tion, food
models,
and
pictures
The long-
term
diabetes
manage-
ment
years
and 6
monthly
group
meet-
ings; bi-
monthly
reviews
by nurse
and
endocri-
nologist
hip cir-
cumfer-
ence mea-
sure-
ments
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goal of
physical
activity
advice
was to
achieve
150 min
of accu-
mulated
physical
activity/
week, in
accor-
dance
with
current
National
Physical
Activity
Recom-
menda-
tions.
To help
achieve
this, goals
were indi-
vidu-
alised for
each pa-
tient ac-
cording
to
mo-
bility, fit-
ness, per-
sonal
prefer-
ence, and
self-
efficacy
for activi-
ties.
Moder-
ate phys-
ical activ-
ity, such
as
walking,
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Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
was en-
couraged,
both
as struc-
tured ac-
tivity
and
activity of
daily liv-
ing.
The
Transthe-
oretical
Model of
Health
Behavior
Change
or
Stage of
Change
Model
under-
pinned
the
lifestyle
interven-
tion to
provide
a frame-
work
for goal-
setting
through-
out the
study
Riccio
2014
To deter-
mine if a
sim-
plified di-
etary ap-
proach
self-man-
aged by
patients
had bene-
ficial im-
pact
on nutri-
List of
recom-
menda-
tions to
modify
dietary
habits
(do not
add salt
at table
or for
cooking;
foods to
Nephrol-
ogist
Face-to-
face; indi-
vidu-
alised
-- -- The goal
of the
study was
to tailor
and mod-
ify diet
for partic-
ipants in
interven-
tion
group
(not oth-
-- Adher-
ence to
diet was
assessed
at reg-
ular inter-
vals (1, 3
and 6th)
, method
for assess-
ing ad-
herence
19/27 in
interven-
tion
group
were ad-
herent
with pro-
tein pre-
scription
whereas
12/
27 in con-
91Dietary interventions for adults with chronic kidney disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
tional
and
metabolic
control of
CKD, to
be accept-
able and
safe
avoid;
replacing
noodles
or bread;
meat, fish
and egg
intake; 4-
5 servings
of fruit
or veg-
etables;
replace-
ment of
noodles
with
legumes
erwise
specified)
was not
reported
trol group
were ad-
herent
with pro-
tein pre-
scription
Sutton
2007
To deter-
mine
whether
of-
fering di-
etary ad-
vice was
ef-
fective in
support-
ing pa-
tients in
adjusting
energy in-
take
The
inter-
vention
group
was
offered
follow-up
dietary
advice
that
would
encour-
age them
to match
energy
intake
with their
estimated
energy
expen-
diture
allow-
ing for
dialysate
calories
and with
a protein
intake of
not < 0.8
to 1.0 g/
kg IBW
Dietitian Face-to-
face
-- Face-
to-face
contact at
baseline
and 4
months.
Suggested
snack
ideas, al-
terations
in food
prepara-
tion, or
modifi-
cation of
portion
sizes
-- -- - 49/
59 partic-
ipants
com-
pleted the
study
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Teng
2013
To exam-
ine effects
of
a targeted
Lifestyle
Modifica-
tion Pro-
gram on
lifestyle
be-
haviours,
knowl-
edge,
and phys-
ical indi-
cators of
CKD
The
Trans
Theoreti-
cal model
using the
stage-of-
change
construct
was
used to
assess the
patient’s
readiness
stage to
promote
be-
haviour
change.
Targeted
inter-
ventions
were
given
according
to the
stage of
change
about
diet and
exercise.
Patients
were en-
couraged
to find
indi-
vidual
methods
of over-
coming
barriers
to regular
exercise.
Written
materials
were
provided
to en-
Regis-
tered
nurse re-
search as-
sistants
Face-to-
face; indi-
vidu-
alised
Clinic Coun-
selling
provided
with each
clinic
visit
The goal
of
the study
to tailor
and mod-
ify diet
for partic-
ipants in
interven-
tion
group
-- To en-
sure the
fidelity
of the
Lifestyle
Modifica-
tion Pro-
gram, all
provided
coun-
selling
and
informa-
tion were
recorded,
and the
inter-
ventions
were
reviewed
by the
investi-
gators at
random
There
was a 64.
4% reten-
tion
rate at 12
months
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Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
courage
adher-
ence to
a CKD
diet. An
infor-
mation
booklet
on pro-
tecting
kidney
function
was pro-
vided and
reviewed
with
patient.
Dis-
cussion
provided
infor-
mation
about
kidney
function
and
disease,
and di-
etary and
lifestyle
manage-
ment
Tzve-
tanov
2014
Examine
the effec-
tiveness
of a
physical
exercise
program
includ-
ing be-
haviour
modifi-
cation
inter-
ventions
and nu-
tritional
Indi-
vidual
physical
training
(one-
to-one
sessions
with a
coach)
using
low-
impact,
low-repe-
tition, re-
sistance-
based
Coach Individ-
ual train-
ing
Pri-
vate envi-
ronment
2 x 1-
hour ses-
sions each
week for
12
months
Standard-
ised pro-
cess
and cur-
ricu-
lum cus-
tomised
to
each indi-
vidual pa-
tients’ en-
ergy level,
medical
wellness,
physi-
Response
to par-
ticipants
muscle
strength,
empow-
erment,
and iden-
tifying
most
impact-
ful be-
haviour/
lifestyle
changes
- Only 4/8
people al-
located to
the con-
trol re-
turned to
the
6 month
follow up
appoint-
ment and
2 for the
12 month
appoint-
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training
for obese
recipients
of a
kidney
trans-
plant
weight
training
with 2 x
1-hour
sessions
each
week in
a private
environ-
ment.
The
objective
of the
exercise
protocol
was to
maximize
adher-
ence,
improve
medical
health,
reduce
pain,
improve
energy,
and
enhance
emo-
tional
wellness
and
quality of
life. Each
session
had a
clearly
defined
protocol
incor-
porating
physical,
educa-
tional,
and
psycho-
logical
aspects
cal status/
limita-
tions, and
emo-
tional life
for each
patient
ment.
Adher-
ence with
the super-
vised re-
habilita-
tion pro-
gram and
follow up
was
100% in
people al-
located to
the inter-
vention
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Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
Zhou
2011b
To inves-
tigate the
effects of
nutrition
interven-
tion and
individu-
alised
nursing
care
on nutri-
tional sta-
tus
and qual-
ity of life
in people
with
ESKD re-
ceiv-
ing peri-
toneal
dialysis
An in-
divid-
ualised
nutrition
inter-
vention
devel-
oped by
dietitian
with
regard
to the
patient’s
nutri-
tional
status,
clinical
condi-
tion, and
charac-
teristics.
The
study
group re-
ceived the
following
inter-
vention:
energy
125 kJ/
kg/d,
protein
1.2 to 1.
3 g/kg/d,
and 70%
to 75%
propor-
tion of
protein as
of high
biological
value.
Oral
enteral
nutrition
supple-
ments
Dieti-
tian and
nurses
Individ-
ual face-
to-face
-- Psycho-
log-
ical sup-
port was
given for
30 min
once-
monthly
over 6
months
Individu-
alised ac-
cord-
ing to nu-
tritional
and clini-
cal status
-- -- Not
reported
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were
used for
patients
who
did not
receive
enough
nutrients
from
food. The
volume
of water
intake
was
equiva-
lent to
the urine
volume
plus 500
mL/d and
sodium
was 3
g/d. In
addition,
nurse
practi-
tioners
provided
psycho-
logical
care, an
individ-
ualised
exercise
program,
and
blood
pressure
treatment
Mediterranean diet
DIRECT
Study
2013
To inves-
tigate the
long-
term
effect of
Mediter-
ranean
diet
Mediter-
ranean
diet:
moder-
ate-fat,
restricted
calorie,
rich in
Dietitian Members
of each
treatment
group
were
assigned
to sub-
-- Dietitians
met with
groups in
weeks 1,
3, 5, and
7, and
thereafter
6 times
during
the 2-year
interven-
tion, an-
other di-
eti-
-- Adher-
ence
with the
diets was
evaluated
by a
validated
Adher-
ence with
study in-
terven-
tion was
95.4% at
first year
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Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
on kidney
function
vegeta-
bles and
low in
red meat,
with
poultry
and fish
replacing
beef and
lamb.
Energy
intake
was
restricted
to 1500
kcal/d for
women
and 1800
kcal/d
for men,
with a
goal of
no more
than
35% of
calories
from fat;
the main
sources
of added
fat were
30 to 45
g of olive
oil and a
handful
of nuts (5
to 7 nuts,
< 20 g)/d
Low
carbo-
hydrate
diet: low-
carbo-
hydrate,
non-re-
stricted-
calorie
diet
groups of
between
17 and
19 par-
ticipants,
with 6
groups
for each
dietary
treatment
group.
Each
group
was
assigned
to a
registered
dietitian
who led
all 6 sub-
groups
of that
dietary
group.
Self-
service
cafeterias
in work-
places
worked
closely
with
dietitians
to adjust
specific
food
items to
specific
diet
groups.
Each
food
item was
provided
with a
label
at 6-week
intervals,
for a total
of 18
sessions
of 90 min
each. The
Israeli
version
of the
diabetes
preven-
tion pro-
gram was
adapted
including
addi-
tional
themes
for each
dietary
change.
In addi-
tion, a
group of
spouses
received
education
tian con-
ducted 10
to 15 min
motiva-
tional
telephone
calls with
patients
who
were hav-
ing diffi-
culty ad-
hering to
the diet
food-
frequency
question-
naire that
included
127 food
items and
three por-
tion-size
pictures
for 17
items. A
subgroup
of par-
ticipants
com-
pleted
two
repeated
24-hour
dietary
recalls
to verify
absolute
intake.
We used a
validated
question-
naire to
assess
physical
activity.
At base-
line, and
at 6, 12,
and 24
months
of follow-
up, the
question-
naires
were self-
admin-
and 84.
6%at sec-
ond year
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aimed to
provide
20 g of
carbohy-
drates/d
for the 2-
month
induction
phase and
immedi-
ately after
religious
holidays,
with a
gradual
increase
to a max-
imum
of 120
g/d to
maintain
weight
loss
Low fat
diet:
Low-fat
calorie
restricted
diet
based on
American
Heart As-
sociation
guide-
lines,
with an
energy
intake
of 1500
kcal/d for
women
and 1800
kcal/d for
men with
30% of
calories
from fat,
10% of
showing
the num-
ber of
calories
and the
number
of grams
of carbo-
hydrates,
fat and
saturated
fat
istered
electron-
ically
through
the work-
place
intranet.
The
15% of
patients
who
request
aid in
complet-
ing the
question-
naires
were
assisted
by the
study
nurse
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calories
from
saturated
fat, and
an intake
of 300
mg of
choles-
terol/d.
Patients
were
coun-
selled to
consume
low-fat
grains,
vegeta-
bles,
fruits,
and
legumes
and to
limit con-
sumption
of ad-
ditional
fats,
sweets,
and high-
fat snacks
This
study was
included
as a post-
hoc anal-
ysis of the
main
study in-
clud-
ing peo-
ple with
CKD
(eGFR
< 60 mL/
min/1.73
m2)
Mekki
2010
To evalu-
ate effect
of nutri-
Nutri-
tional
-- Face-to-
face
Nephrol-
ogy ward
-- -- -- Recall
and
By
90 days,
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tional ad-
vice
on dyslip-
idaemia
and
biomark-
ers
advice
based
on the
National
Kidney
Foun-
dation-
Kidney
Disease
Out-
comes
Quality
Initiative
guideline
(energy
intake 0.
12 MJ/
kg BW/
d, protein
0.75 g/
kg BW/
d, lipid
intake
35%, and
carbo-
hydrates
55%
of total
energy
intake).
Dietary
recom-
men-
dations
were
modified
and
adapted
to a
Mediter-
ranean
diet with
increased
intake of
mono-
unsat-
urated
fatty
record
every
4 days,
patients
inter-
viewed by
trained
inter-
viewers
using
adapted
and
structures
ques-
tionnaire
regarding
24 hour
dietary
intake.
Serving
sizes were
estimated
by the
use of
the food
portion
model
hand-
book. Di-
mensions
of dishes,
utensils
and
foods
were
mea-
sured,
and
the por-
tion sizes
were esti-
mated ac-
curately.
the quali-
tative dis-
tri-
bution of
nutrients
had a ten-
dency to
be closer
to the rec-
om-
mended
diet
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Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
acids
(MUFA),
poly-un-
saturated
fatty
acids
(PUFA)
, and
fibres.
Patients
were
asked to
consume
olive oil
and nuts
for sea-
sonings,
whole
grains (50
g bread
at each
meal, 250
g cereal
or starch
once
a day)
, fruits
(once
a day),
vegeta-
bles (200
g twice
a day)
and fish
(twice a
week).
A list of
foods rich
in salt,
potas-
sium and
phospho-
rus was
provided.
In ad-
dition,
patients
received
The con-
sumed
foods
were con-
verted
into vari-
ous
nutrients
using the
software
GENI
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advice
about
cooking
methods
best
suited to
adher-
ence
Sta-
chowska
2005
To verify
the effect
of the
Mediter-
ranean
diet
on risk
factors of
atheroscle-
rosis in
people
with a
kidney
trans-
plant
This diet
featured
carbo-
hydrates
with a
low GI
(poor in
glucose,
simple
carbohy-
drates,
and amy-
lose, rich
in cel-
lulose).
Approved
diet con-
stituents
included
cereals,
pulse,
whole-
rye bread,
veg-
etables
(cooked
or fresh),
oat flakes
(cooked)
, and
noodles
prepared
al dente.
Amylose-
rich
foods,
sweets,
and sweet
drinks
-- -- -- -- -- -- Di-
etary ad-
herence
was ascer-
tained ev-
ery 4
weeks us-
ing ques-
tion-
naires
(24-
h food di-
aries) and
monitor-
ing oleic
acid con-
tent
in plasma
triglyc-
erides
The con-
tent of
oleic acid
in triglyc-
erides
contin-
ued to in-
crease in
the study
group
and
remained
un-
changed
in con-
trols (Ta-
ble 2)
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were pro-
hibited.
Breakfast
was the
main
meal,
providing
39% 2%
of daily
calorie
intake,
whereas
supper
provided
the least
(16%
3%). In
the study
group,
daily
energy
intake
was at-
tributed
as fol-
lows:
47%
carbohy-
drates,
38% fatty
acids
(includ-
ing 10%
saturated,
22%
monoun-
saturated,
and 6%
polyun-
saturated
species),
and 15%
protein.
Choles-
terol
and fibre
supply
was 165
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± 17 mg/
d and 47
± 9 g/d,
respec-
tively.
The sig-
nificant
content
of fibre in
the diet
was at-
tributed
to the use
of fresh,
unpro-
cessed
food,
elimi-
nation
of semi
processed
products,
and daily
intake
of pulse/
cereal (e.
g. buck-
wheat,
barley)
/veg-
etables/
whole-
meal rye
bread.
The
domi-
nating
fatty acid
was oleic
acid from
olive
oil and
erucic
acid-poor
rapeseed
oil. Pa-
tients
con-
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sumed 30
mL cold-
pressed
olive oil/
d (fresh
salads)
and
prepared
their
cooked
meals ex-
clusively
with
rapeseed
oil. All
other
oils were
totally
elimi-
nated
from
the diet.
Patients
con-
sumed
approxi-
mately 30
g daily of
products
rich in
alpha-to-
copherol
and
alpha-
linolenic
acid C
18:3 n-3
(grains,
flaxseed,
nuts)
. The
patients
were
advised to
consume
fresh
vegeta-
bles with
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every
meal.
The daily
animal
protein
con-
sumption
was 25
to 50 g
for men
and 23 to
46 g for
women,
repre-
senting
one third
of the
total
protein.
No ad-
ditional
vitamin
supple-
menta-
tion was
offered
Increased fruit and vegetables
Goraya
2013
To evalu-
ate
increased
intake of
base-
produc-
ing fruits
and veg-
etables on
kid-
ney func-
tion and
metabolic
acidosis
Patients
received
fruits and
vegeta-
bles free
of charge,
dis-
tributed
from
the food
bank in
amounts
to reduce
potential
renal
acid load
by half.
Prescrip-
tions em-
phasised
Dieti-
tian pre-
scribed
Individu-
als were
not given
specific
dietary
instruc-
tions and
they in-
tegrated
the pre-
scribed
fruits and
vegeta-
bles into
their diets
as they
wished.
To better
assure
-- -- -- -- Formal
assess-
ment
methods
was not
em-
ployed;
however
to ensure
partic-
ipants
con-
sumed
required
amount
of fruit
and veg-
etables,
--
107Dietary interventions for adults with chronic kidney disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
base-pro-
ducing
fruits and
vegeta-
bles such
as apples,
apricots,
oranges,
peaches,
pears,
raisins,
straw-
berries,
carrots,
cauliflower,
eggplant,
lettuce,
potatoes,
spinach,
tomatoes,
and
zucchini
that each
patient
ate all
the pre-
scribed
fruits
and veg-
etables,
the pre-
scribed
amount
was given
for each
house-
hold
person
fruit
and veg-
etables
were dis-
tributed
for whole
family/
house-
hold
Goraya
2014
To evalu-
ate
increased
intake of
base-
produc-
ing fruits
and veg-
etables on
kid-
ney func-
tion and
metabolic
acidosis
Patients
received
fruits and
vegeta-
bles free
of charge,
dis-
tributed
from
the food
bank in
amounts
to reduce
potential
renal
acid load
by half.
Prescrip-
tions em-
phasised
base-pro-
ducing
fruits and
vegeta-
bles such
as apples,
Dieti-
tian pre-
scribed
Individu-
als were
not given
specific
dietary
instruc-
tions and
they in-
tegrated
the pre-
scribed
fruits and
vegeta-
bles into
their diets
as they
wished.
To better
assure
that each
patient
ate all
the pre-
scribed
fruits
-- -- -- -- Formal
assess-
ment
methods
was not
em-
ployed;
however
to ensure
partic-
ipants
con-
sumed
required
amount
of fruit
and veg-
etables,
fruit
and veg-
etables
were dis-
tributed
--
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Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
apricots,
oranges,
peaches,
pears,
raisins,
straw-
berries,
carrots,
cauliflower,
eggplant,
lettuce,
potatoes,
spinach,
tomatoes,
and
zucchini
and veg-
etables,
the pre-
scribed
amount
was given
for each
house-
hold
person
for whole
family/
house-
hold
Carbohydrate-restricted, low-iron, polyphenol enriched (CR-LIPE) diet
Facchini
2003
To evalu-
ate
whether
dietary
modifica-
tion had
effect on
progres-
sion of
CKD
CR-LIPE
diet; 50%
reduction
in carbo-
hydrate
intake;
substi-
tution
of iron-
enriched
meats
(beef and
pork)
with
iron-poor
white
meats
(poultry
and fish)
and with
protein-
enriched
food
items
known to
inhibit
iron ab-
sorption
(dairy;
-- -- -- -- -- -- Serum
fer-
ritin level;
to assess
adher-
ence with
low iron
diet
Serum
ferritin
level de-
creased in
group on
CR-LIPE
diet
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Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
eggs; soy)
; elimina-
tion of all
beverages
other
than tea,
water and
red wine;
exclusive
use of
polyphe-
nol-
enriched
extra-
virgin
olive oil
High-nitrogen, low carbohydrate diet
Whittier
1985
Whether
a high-ni-
tro-
gen, low
carbohy-
drate diet
could re-
sult
in a posi-
tive nitro-
gen
balance
and fewer
cushin-
goid side
effects
in the im-
medi-
ate post-
trans-
plant pe-
riod
On the
morning
of the 4th
postop-
erative
day, the
patients
were
randomly
assigned
to receive
either the
control or
the exper-
imental
diet. A
general
daily diet
order
was pre-
scribed
for all
patients;
it con-
sisted of
800 mL
fluid re-
striction
plus an
Dietitian Diets
were pre-
pared in
batches in
the
metabolic
kitchen
by a re-
search di-
etician.
One meal
from each
batch was
slurried
and anal-
ysed for
nitrogen
and elec-
trolyte
content.
The re-
mainder
of the
diet trays
from the
batch
were
frozen
and mi-
Inpatient
General
Clinical
Research
Cen-
tre for 4-
week du-
ration of
study
Contin-
uous as-
sessment
The com-
position
of the diet
was deter-
mined ac-
cording
to inclu-
sion into
either the
treatment
or control
group
-- Uneaten
food from
each tray
was
weighed
and sub-
tracted
from the
daily
total in-
take. The
patients
were en-
couraged
to report
any non-
tray items
(e.
g. candy,
fruit,
snacks) to
the di-
etician so
that
the totals
could re-
flect
Both
groups
ingested a
similar
amount
of
total calo-
ries, and
when fac-
tored by
weight,
intakes
per kg of
body
weight
were very
close to
the objec-
tive of 28
to 30
calories/
kg of
body
weight.
As pre-
scribed,
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Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
amount
equal to
the urine
volume/
d, 2 g
sodium,
80 mEq
potas-
sium,
800 to
1200
mg of
calcium,
and 30
calories/
kg. Total
calories
and
content
of the
diet, in
identical
propor-
tions,
were
adjusted
up or
down per
kilogram
to the
nearest
10 kg for
patients
who
weighed
more
or less
than 70
kg since
the ideal
body
weight
of these
patients
varied
from 50
to 90 kg
prior to
crowaved
prior to
serving
to the
patient.
Uneaten
food
from each
tray was
weighed
and sub-
tracted
from the
daily total
intake
actual in-
take
the
control
group’s
intake of
carbo-
hydrate
was sig-
nificantly
greater
and the
protein
intake
was sig-
nificantly
less than
that of
the exper-
imental
diet
group.
In the
control
group
there
was little
variation
in protein
or caloric
intake
from
patient to
patient
with the
excep-
tion of
patient 9,
whereas
in the
experi-
mental
group,
the
protein
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Table 2. TIDieR framework of intervention descriptions for included studies (Continued)
trans-
planta-
tion
intake
varied
from 1.
4 g/kg/d
up to the
goal of 3.
0 g/kg/d
BMI - body mass index; (I)BW - (individual) body weight- CKD - chronic kidney disease; eGFR - estimated glomerular filtration rate;
GI - glycaemic index
Table 3. Narrative description of health-related quality of life outcomes
Study ID Tool Description
Dietary counselling
Campbell 2008 KidneyDisease Quality of Life Short FormVersion 1.
3 (combining the SF-36with a kidney-disease specific
module)
”There was a clear trend for amean increase in ratings
from the intervention group with a clinically signif-
icant mean improvement in 13 of the 18 sub-scales
frombaseline toweek 12, indicated by an effect size of
0.2 or greater...“. There was a statistically significant
difference in mean change for scores of symptoms of
kidney disease (7.1 (0.1-14.1) P = 0.047); cognitive
functioning (14.6 (5.4-23.7) P = 0.003); and vitality
(12.0 (4.6-19.5) P = 0.002) in favour of the interven-
tion.”
Chanwikrai 2012 -- Not reported
Flesher 2011 Self-Management Questionnaire “Overall, the experimental group showed ’improve-
ment’ in exercise frequency, concern over health con-
dition, and frequency of visits to health providers
or hospitalisation. Overall the control group answers
indicated an improvement in their communication
with health providers in asking question and dis-
cussing personal issues.”
Leon 2006 Kidney Disease Quality of Life questionnaire (com-
bining the SF-36 with a kidney-disease specific mod-
ule)
“There were no differences between intervention and
control patients in quality-of-life subscales, includ-
ing general health, physical functioning, emotional
well-being, social function, pain, and dialysis-related
symptoms.”
Orazio 2011 -- Not reported
Riccio 2014 -- Not reported
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Table 3. Narrative description of health-related quality of life outcomes (Continued)
Sutton 2007 -- Not reported
Teng 2013 52-item HPLP-IIC questionnaire Intervention had a significant effect on health respon-
sibility and physical activity, but not stress manage-
ment, interpersonal relations, spiritual growth or nu-
trition
Tzvetanov 2014 SF-36 “The mean SF-36 score at 6 months was significantly
higher in the intervention group compared with the
control group (583±13 vs 436±22, P = 0.008), re-
flecting an improved perception of health status. ...
The intervention grouphad improvements compared
with the control group in the domains of vitality and
general health.”
Zhou 2011b KidneyDisease Quality of Life Short FormVersion 1.
3 (combining the SF-36with a kidney-disease specific
module)
“Prior to intervention, the differences in KDTA and
SF-36 scores were not statistically significant in both
groups (P >0.05 for all). After intervention, both
KDTA and SF-36 scores were improved in the study
group, but decreased in the control group. The dif-
ference in KDTA (P = 0.001) and SF-36 scores (P =
0.001) before and after intervention were statistically
significant in both groups (Table 2).”
Mediterranean diet
DIRECT Study 2013 -- Not reported
Mekki 2010 -- Not reported
Stachowska 2005 -- Not reported
Increased fruit and vegetables
Goraya 2013 -- Not reported
Goraya 2014 -- Not reported
Carbohydrate-restricted, low-iron-available, polyphenol-enriched diet
Facchini 2003 -- Not reported
High-protein, low carbohydrate diet
Whittier 1985 -- Not reported
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Table 4. Adverse events
Study Adverse events reported in study
Campbell 2008a Mortality; need for dialysis
Chanwikrai 2012 Not reported
DIRECT Study 2013 Not reported
Facchini 2003 Not reported
Flesher 2011 Not reported
Goraya 2013 No participants meeting eGFR and plasma potassium criteria developed plasma potassium concentration
>5.0 mEq/L
Goraya 2014 Not reported
Leon 2006 Not reported
Mekki 2010 Not reported
Orazio 2011 Not reported
Riccio 2014 Not reported
Stachowska 2005 Not reported
Sutton 2007 Mortality; transfer from PD to HD
Teng 2013 Not reported
Tzvetanov 2014 Not reported
Whittier 1985 Dialysis due to elevated blood urea and potassium concentrations
Zhou 2011b Not reported
eGFR - estimated glomerular filtration rate; HD - haemodialysis; PD - peritoneal dialysis
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A P P E N D I C E S
Appendix 1. Electronic search strategies
Database Search terms
CENTRAL 1. MeSH descriptor: [Diet] explode all trees
2. MeSH descriptor: [Diet Therapy] explode all trees
3. MeSH descriptor: [Dietary Carbohydrates] explode all trees
4. MeSH descriptor: [Calcium, Dietary] this term only
5. MeSH descriptor: [Potassium, Dietary] this term only
6. MeSH descriptor: [Dietary Fats] explode all trees
7. MeSH descriptor: [Dietary Fiber] explode all trees
8. MeSH descriptor: [Dietary Proteins] explode all trees
9. MeSH descriptor: [Dietary Supplements] this term only
10. MeSH descriptor: [Micronutrients] explode all trees
11. MeSH descriptor: [Nutritional Requirements] explode all trees
12. MeSH descriptor: [Nutritional Status] this term only
13. MeSH descriptor: [Nutrition Therapy] this term only
14. MeSH descriptor: [Keto Acids] explode all trees
15. MeSH descriptor: [Amino Acids, Essential] explode all trees
16. MeSH descriptor: [Folic Acid] this term only
17. MeSH descriptor: [Patient Education as Topic] this term only
18. diet$ or nutrition$:ti,ab,kw (Word variations have been searched)
19. {and #17-#18}
20. (diet* or nutrition*) and (protein or fat or cholesterol or omega-3* or carbohydrates or glyc?emic index or fibre
or fiber or folate or folic acid):ti,ab,kw (Word variations have been searched)
21. (diet* or nutrition*) and (mediterranean or vegetarian or DASH or macrobiotic):ti,ab,kw (Word variations have
been searched)
22. (diet* or nutrition*) and (phosphorus or calcium or potassium or micronutrient* or vitamin*):ti,ab,kw (Word
variations have been searched)
23. (diet* or nutrition*) and (supplement* or amino acid* or keto acid*):ti,ab,kw (Word variations have been
searched)
24. (diet$ or nutrition*) and (advice* or education* or counselling):ti,ab,kw (Word variations have been searched)
25. {or #1-#16, #19-#24}
26. MeSH descriptor: [Kidney Diseases] explode all trees
27. MeSH descriptor: [Renal Replacement Therapy] explode all trees
28. MeSH descriptor: [Renal Insufficiency] explode all trees
29. MeSH descriptor: [Renal Insufficiency, Chronic] explode all trees
30. dialysis:ti,ab,kw (Word variations have been searched)
31. hemodialysis or haemodialysis:ti,ab,kw (Word variations have been searched)
32. hemofiltration or haemofiltration:ti,ab,kw (Word variations have been searched)
33. hemodiafiltration or haemodiafiltration:ti,ab,kw (Word variations have been searched)
34. kidney disease* or renal disease* or kidney failure or renal failure:ti,ab,kw (Word variations have been searched)
35. ESRF or ESKF or ESRD or ESKD:ti,ab,kw (Word variations have been searched)
36. CKF or CKD or CRF or CRD:ti,ab,kw (Word variations have been searched)
37. CAPD or CCPD or APD:ti,ab,kw (Word variations have been searched)
38. predialysis or pre-dialysis:ti,ab,kw (Word variations have been searched)
39. MeSH descriptor: [Diabetic Nephropathies] this term only
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(Continued)
40. diabetic kidney disease*:ti,ab,kw (Word variations have been searched)
41. diabetic nephropath*:ti,ab,kw (Word variations have been searched)
42. {or #26-#41}
43. {and #25, #42}
MEDLINE 1. Diet/
2. Diet Therapy/
3. Caloric Restriction/
4. Diabetic Diet/
5. Diet, Carbohydrate-Restricted/
6. Diet, Fat-Restricted/
7. Diet, Gluten-free/
8. Diet, Macrobiotic/
9. Diet, High-Fat/
10. Diet, Mediterranean/
11. Diet, Paleolithic/
12. Diet, Protein-Restricted/
13. Diet, Reducing/
14. Diet, Sodium-Restricted/
15. Diet, Vegetarian/
16. Diet, Atherogenic/
17. Diet Fads/
18. Diet, Cariogenic/
19. Diet, Western/
20. exp Dietary Carbohydrates/
21. Calcium, Dietary/
22. Potassium, Dietary/
23. exp Dietary Fats/
24. exp Dietary Fiber/
25. exp Dietary Proteins/
26. Dietary Supplements/
27. exp Micronutrients/
28. exp Nutritional Requirements/
29. Nutritional Status/
30. Nutrition Therapy/
31. Energy Intake/
32. Fasting/
33. ketogenic diet/
34. Portion Size/ or Serving Size/
35. exp Keto Acids/
36. exp Amino Acids, Essential/
37. exp Amino Acids/
38. Folic Acid/
39. Patient Education as Topic/
40. (diet$ and (mediterranean or vegetarian or DASH)).tw.
41. (diet$ and (supplement$ or amino acid$ or amino acids or keto acid$)).tw.
42. ((diet$ or nutrition$) and (advice$ or education$ or counselling)).tw.
43. or/1-42
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(Continued)
44. Kidney Diseases/
45. exp Renal Replacement Therapy/
46. Renal Insufficiency/
47. exp Renal Insufficiency, Chronic/
48. dialysis.tw.
49. (hemodialysis or haemodialysis).tw.
50. (hemofiltration or haemofiltration).tw.
51. (hemodiafiltration or haemodiafiltration).tw.
52. (kidney disease* or renal disease* or kidney failure or renal failure).tw.
53. (ESRF or ESKF or ESRD or ESKD).tw.
54. (CKF or CKD or CRF or CRD).tw.
55. (CAPD or CCPD or APD).tw.
56. (predialysis or pre-dialysis).tw.
57. or/44-56
58. Diabetic Nephropathies/
59. diabetic nephropath$.tw.
60. diabetic kidney$.tw.
61. or/58-60
62. Diabetes Mellitus/
63. exp diabetes mellitus, type 1/
64. exp diabetes mellitus, type 2/
65. or/62-64
66. proteinuria/ or albuminuria/
67. proteinuria$ or albuminuria$ or microalbuminuria$ or macroalbuminuria$).tw.
68. or/66-67
69. and/65,68
70. or/61,69
71. or/57,70
72. and/43,70
EMBASE 1. nutritional counseling/
2. nutrition education/
3. nutritional health/
4. nutritional assessment/
5. nutrition/
6. exp diet/
7. exp diet therapy/
8. exp dietary intake/
9. exp diet restriction/
10. or/1-9
11. exp renal replacement therapy/
12. kidney disease/
13. chronic kidney disease/
14. kidney failure/
15. chronic kidney failure/
16. mild renal impairment/
17. stage 1 kidney disease/
18. moderate renal impairment/
19. severe renal impairment/
117Dietary interventions for adults with chronic kidney disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
20. end stage renal disease/
21. renal replacement therapy-dependent renal disease/
22. kidney transplantation/
23. (hemodialysis or haemodialysis).tw.
24. (hemofiltration or haemofiltration).tw.
25. (hemodiafiltration or haemodiafiltration).tw.
26. dialysis.tw.
27. (CAPD or CCPD or APD).tw.
28. (kidney disease* or renal disease* or kidney failure or renal failure).tw
29. (CKF or CKD or CRF or CRD).tw.
30. (ESRF or ESKF or ESRD or ESKD).tw.
31. (predialysis or pre-dialysis).tw.
32. ((kidney or renal) adj (transplant* or graft* or allograft*)).tw
33. Diabetic Nephropathies/
34. diabetic nephropath$.tw.
35. diabetic kidney disease$.tw.
36. or/11-35
37. and/10,36
Appendix 2. Risk of bias assessment tool
Potential source of bias Assessment criteria
Random sequence generation
Selection bias (biased allocation to interventions) due to inade-
quate generation of a randomised sequence
Low risk of bias: Random number table; computer random num-
ber generator; coin tossing; shuffling cards or envelopes; throwing
dice; drawing of lots; minimization (minimization may be imple-
mented without a random element, and this is considered to be
equivalent to being random)
High risk of bias: Sequence generated by odd or even date of birth;
date (or day) of admission; sequence generated by hospital or
clinic record number; allocation by judgement of the clinician; by
preference of the participant; based on the results of a laboratory
test or a series of tests; by availability of the intervention
Unclear: Insufficient information about the sequence generation
process to permit judgement
Allocation concealment
Selection bias (biased allocation to interventions) due to inade-
quate concealment of allocations prior to assignment
Low risk of bias: Randomisation method described that would not
allow investigator/participant to know or influence intervention
group before eligible participant entered in the study (e.g. central
allocation, including telephone, web-based, and pharmacy-con-
trolled, randomisation; sequentially numbered drug containers of
identical appearance; sequentially numbered, opaque, sealed en-
velopes)
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(Continued)
High risk of bias:Using an open random allocation schedule (e.g. a
list of random numbers); assignment envelopes were used without
appropriate safeguards (e.g. if envelopes were unsealed or non-
opaque or not sequentially numbered); alternation or rotation;
date of birth; case record number; any other explicitly unconcealed
procedure
Unclear: Randomisation stated but no information on method
used is available
Blinding of participants and personnel
Performance bias due to knowledge of the allocated interventions
by participants and personnel during the study
Low risk of bias: No blinding or incomplete blinding, but the re-
view authors judge that the outcome is not likely to be influenced
by lack of blinding; blinding of participants and key study per-
sonnel ensured, and unlikely that the blinding could have been
broken
High risk of bias: No blinding or incomplete blinding, and the
outcome is likely to be influenced by lack of blinding; blinding
of key study participants and personnel attempted, but likely that
the blinding could have been broken, and the outcome is likely
to be influenced by lack of blinding
Unclear: Insufficient information to permit judgement
Blinding of outcome assessment
Detection bias due to knowledge of the allocated interventions by
outcome assessors
Low risk of bias:Noblinding of outcome assessment, but the review
authors judge that the outcome measurement is not likely to be
influenced by lack of blinding; blinding of outcome assessment
ensured, and unlikely that the blinding could have been broken
High risk of bias: No blinding of outcome assessment, and the
outcome measurement is likely to be influenced by lack of blind-
ing; blinding of outcome assessment, but likely that the blinding
could have been broken, and the outcome measurement is likely
to be influenced by lack of blinding
Unclear: Insufficient information to permit judgement
Incomplete outcome data
Attrition bias due to amount, nature or handling of incomplete
outcome data
Low risk of bias: No missing outcome data; reasons for missing
outcome data unlikely to be related to true outcome (for survival
data, censoring unlikely to be introducing bias); missing outcome
data balanced in numbers across intervention groups, with similar
reasons for missing data across groups; for dichotomous outcome
data, the proportion ofmissing outcomes comparedwith observed
event risk not enough to have a clinically relevant impact on the
intervention effect estimate; for continuous outcome data, plau-
sible effect size (difference in means or standardized difference in
means) among missing outcomes not enough to have a clinically
relevant impact on observed effect size; missing data have been
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(Continued)
imputed using appropriate methods
High risk of bias: Reason for missing outcome data likely to be
related to true outcome, with either imbalance in numbers or rea-
sons for missing data across intervention groups; for dichotomous
outcome data, the proportion ofmissing outcomes comparedwith
observed event risk enough to induce clinically relevant bias in
intervention effect estimate; for continuous outcome data, plau-
sible effect size (difference in means or standardized difference in
means) among missing outcomes enough to induce clinically rel-
evant bias in observed effect size; ‘as-treated’ analysis done with
substantial departure of the intervention received from that as-
signed at randomisation; potentially inappropriate application of
simple imputation
Unclear: Insufficient information to permit judgement
Selective reporting
Reporting bias due to selective outcome reporting
Low risk of bias: The study protocol is available and all of the
study’s pre-specified (primary and secondary) outcomes that are of
interest in the review have been reported in the pre-specified way;
the study protocol is not available but it is clear that the published
reports include all expected outcomes, including those that were
pre-specified (convincing text of this nature may be uncommon)
High risk of bias: Not all of the study’s pre-specified primary out-
comes have been reported; one or more primary outcomes is re-
ported using measurements, analysis methods or subsets of the
data (e.g. subscales) that were not pre-specified; one or more re-
ported primary outcomes were not pre-specified (unless clear jus-
tification for their reporting is provided, such as an unexpected
adverse effect); one or more outcomes of interest in the review are
reported incompletely so that they cannot be entered in a meta-
analysis; the study report fails to include results for a key outcome
that would be expected to have been reported for such a study
Unclear: Insufficient information to permit judgement
Other bias
Bias due to problems not covered elsewhere in the table
Low risk of bias: The study appears to be free of other sources of
bias.
High risk of bias: Had a potential source of bias related to the spe-
cific study design used; stopped early due to some data-dependent
process (including a formal-stopping rule); had extreme baseline
imbalance; has been claimed to have been fraudulent; had some
other problem
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Unclear: Insufficient information to assess whether an important
risk of bias exists; insufficient rationale or evidence that an iden-
tified problem will introduce bias
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
None.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Cardiovascular Diseases [epidemiology]; Diet, Carbohydrate-Restricted [statistics & numerical data]; Diet, Mediterranean [statistics
& numerical data]; Diet, Protein-Restricted [statistics & numerical data]; Disease Progression; Fruit; Kidney Failure, Chronic [diet
therapy; mortality]; Kidney Transplantation [statistics & numerical data]; Quality of Life; Randomized Controlled Trials as Topic;
Renal Insufficiency, Chronic [∗diet therapy; mortality]; Renal Replacement Therapy [statistics & numerical data]; Vegetables
MeSH check words
Adult; Humans
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